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Avian pathogenic Escherichia. coli (APEC) and Campylobacter are pathogenic threats to
poultry and human health, respectively. In this study, the prevalence of these pathogens in
Mississippi broilers and their antimicrobial resistance (AMR) properties were investigated, and a
multidrug-resistant APEC strain (APEC-O2-MS1170) was further explored by whole-genome
sequencing (WGS). The efficacy of in ovo injection of Lactobacillus in reducing the APEC in
broilers was evaluated. Results revealed a high prevalence of APEC and Campylobacter in
broilers and broiler products. A lot of isolates were resistant to antibiotics of different sorts.
Moreover, the in ovo administration of Lactobacillus did not reduce the incidence of APEC. The
WGS of APEC-O2-MS1170 revealed its detailed AMR and virulence properties and alerted a
potential zoonotic risk. In conclusion, the Lactobacillus did not reduce the incidence of APEC in
broilers, and the prevalence and AMR of APEC and Campylobacter are still challenges faced by
the poultry industry.
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CHAPTER I
LITERATURE REVIEW
Introduction
Poultry and poultry consumption
The total human population is increasing worldwide, till the year 2050, the forecast
population will be more than 9 billion (United Nations, Department of Economic and Social
Affairs). As a result, food is in great demand, especially the mean for protein. Poultry is an
affordable source of high-quality protein from meat and eggs, which plays an important role in
fighting hunger and malnutrition. Under the general term of poultry, chickens, turkeys, ducks,
geese, pigeons, guinea fowl, pheasants are in the list. The increasing need for high-quality meat
makes poultry popular, and the poultry industry becomes a large business over the world,
partially due to the low cost associated with its high production efficiency. The poultry meat
industry is consisting of the broiler and turkey industries. According to the report in 2019,
poultry meat represents the most consumed meat in the United States. Since 2015, per capita
consumption of poultry (chicken and turkey) has become more than the consumption of total red
meat (beef and pork). Broilers count for the top one production and consumption among all
poultry meat. In 2019, over 9.2 billion broiler chickens were produced, weighing more than 58
billion pounds, and the consumer retail expenditures for chickens were up to $95 billion
(https://www.nationalchickencouncil.org). During the year 2019, the top 5 broiler producing
states were Georgia, Arkansas, Alabama, North Carolina, and Mississippi in the United States
1

(USDA, National Agricultural Statistics Service, June 2020), and the broiler production from
these states occupied nearly half of the total production during the year 2019 in the United
States.
Pathogen challenges to the poultry industry
The pathogens are a significant challenge to the poultry industry due to the infectious
diseases in poultry, threatening poultry health and welfare. The pathogens spread in the poultry
flock, including E. coli, Salmonella, Staphylococcus, etcetera. These pathogens potentially cause
colibacillosis, salmonellosis, and staphylococcosis in poultry; these microbial diseases are
always associated with economic losses to the poultry industry. The poultry meat contaminated
with foodborne pathogens can cause infections and illnesses in humans, which becomes a food
safety concern to the public. The foodborne pathogens carried by poultry such as
Campylobacter, Salmonella, and Clostridium perfringens can cause foodborne illness in humans,
sometimes called “food poisoning.” The common symptoms of consuming poultry products
contaminated with these pathogens include fever, vomiting, nausea, and stomachache
(https://www.cdc.gov/foodsafety/symptoms). The infection cases of consumers bring adverse
effects to the producers’ reputation and even make them face financial compensation. Overall,
pathogens make poultry industries face a severe economic burden, which translates into billion
dollars losses annually for all facets of the world’s poultry industry.
Pathogen transmission routes
The pathogens could widespread in the chicken flock among individuals; the
transmission route among chickens could occur horizontally or vertically, sometimes both (Chen
et al., 2006). The horizontal transmission among chickens of the same generation possibly
2

happens when the chickens contact each other. An indirect route can also occur with a medium,
such as feed, water, insects, farmworkers, equipment, and vehicles. Through this way, the
bacterial pathogen could quickly and broadly spread among the flock. The vertical transmission
stands for the transmission from breeders or layers to the offspring by eggs. The pathogens could
be carried either inside the egg or on the surface. The pathogen carried by one individual also has
the chance of horizontal transmission to others when the eggs are incubated, following by the
newly hatched chicks are brooded together, or during the raised period at the grow-out farm.
That is how pathogens horizontal and vertical transmission occurs both in the poultry.
Poultry is a vehicle that transfers foodborne pathogens to humans. During the processing
and deboning, the bacteria may transfer from feathers to the skin; moreover, the skin of poultry
carcass and the surface of chicken meat contact with operators and equipment surfaces and is
therefore easily cross-contaminated (Álvarez-Astorga et al., 2002). Also, there is a high
possibility of bacterial contamination due to the leaking gut. The gastrointestinal tract hosts a
large number of bacteria, which is a significant reservoir of foodborne pathogens that potentially
contaminate the parts and carcasses. Fresh poultry meat is a good source for bacterial pathogens
growth because of the moist and rich protein. The cold chain management in meat supply plays
an important role in maintaining the meat quality and safety by inhibiting bacterial pathogens'
growth. However, the processed meat without proper cold chain management will allow the
bacteria to grow and multiply, and increase the risk of meat contamination. When consumers eat
these meat undercooked or share the cutting boards or tableware contaminated by the meat, they
are easily affected. Therefore, for consumers, effective ways to avoid the foodborne pathogens
from the poultry products are thoroughly cooking the meat, separate the cutting board for raw
meat and ready-to-eat food, and keep the kitchen hygiene.
3

Avian Pathogenic Escherichia coli (APEC) in Poultry
Introduction of Escherichia coli
Escherichia coli (E. coli) is a Gram-negative, non-spore-forming, rod-shaped bacteria. It
is facultative anaerobes at the best growth temperature of 37 °C. E. coli commonly distributed in
the environment and exist in human and animal intestine. Most of the E. coli are non-pathogenic;
they are harmless as an important component of intestinal microflora. However, some pathogenic
E. coli strains cause food poisoning in humans and animals' infectious diseases (Köhler and
Dobrindt, 2011). Human pathogenic E.coli are distinguished by the type of infections, including
intestinal pathogenic E. coli (IPEC), uropathogenic E. coli (UPEC), neonatal meningitisassociated E. coli (NMEC), and sepsis-causing E. coli (SEPEC) (Johnson and Russo, 2002;
Russo and Johnson, 2000). The pathogenic E. coli associated with infectious disease in poultry is
avian pathogenic E. coli (APEC). The pathogenic E. coli have acquired a number of virulence
genes that differ from the non-pathogenic E. coli. These pathogenic E. coli cause different types
of infections to the host, cause diseases with distinguished symptoms.
Introduction of APEC
Escherichia coli (E. coli) strains that lead to poultry systemic disease are identified as
avian pathogenic E. coli (APEC). APEC is the pathogen associated with extraintestinal
infections in poultry and other livestock. It frequently affects broilers, layers, turkeys, and ducks,
causing various diseases called colibacillosis. APEC is one of the most important pathogens
responsible for infectious diseases among chickens and other avian species (Collingwood et al.,
2014), which results in significant mortality and morbidity in the poultry industry around the
world (Ewers et al., 2004).
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The possible infection routes of APEC to the broilers are through the respiratory tract and
intestinal tract. The upper respiratory tract infection is considered the first step in the
pathogenesis of colibacillosis; it has been proven that APEC is able to adhere and invade the
tracheal epithelium (Ramírez et al., 2009). Following, APEC can access the bloodstream and
invade other extraintestinal organs, such as the heart, liver, and the lung (Vandemaele et al.,
2002). As a result, it potentially leads to pericarditis and perihepatitis, and other related diseases
(Dziva and Stevens, 2008). The poultry intestinal tract is an essential reservoir for APEC; it was
reported by Harry and Hemsley (1965) that approximately 10% to 15% of avian intestinal E. coli
are potentially pathogenic APEC serotypes. APEC that has settled in the intestinal tract is easily
spread into the environment by feces. On the poultry farm, litter contains feces, feed residue,
bedding materials, and feathers (Chen and Jiang, 2014), which may become a source of
contamination with pathogens such as APEC. The bacterial pathogen may spread through dry
dust in the air and by the feed, causing cross-contamination to other healthy chickens through the
respiratory and intestinal passageways.
Serotyping is a method for E. coli classification. The APEC institute a large group of
diverse serotypes that cause disease in poultry. The classical typing of E. coli showing the
serotype O1, O2, O8, O35, and O78 are positively associated with avian colibacillosis (La
Ragione and Woodward, 2002). Among which, serogroups O2 and O78 are associated with
nearly 80% of disease cases worldwide and are the primary serogroups in colibacillosis
outbreaks (Knobl et al., 2012). From the four main E. coli phylogenetic groups (A, B1, B2, and
D), B2 and D are associated with a higher occurrence of APEC phylogenetic groups (Ramadan et
al., 2016).

5

Colibacillosis in poultry
Colibacillosis can occur in all types of birds at any age. However, some factors increase
the infection rate of avian colibacillosis:
a. Immune deficiency of the birds (Koncicki et al., 2012).
b. Poor house environment conditions with a high level of dust or ammonia also
contribute to the respiratory stress of birds (Davis and Morishita, 2005).
c. Predisposing factors, such as the infection of bronchitis virus and Newcastle disease
virus (Ariaans et al., 2008).
Poultry with the condition describes above are easily get a secondary infection by APEC.
The primary infection that happens with either virus or bacteria could accelerate the process of
APEC infection. A study has concluded that the secondary APEC infection occurred after the
primary infections of the bronchitis virus, Newcastle disease virus (NDV), and Mycoplasma spp
(Provence and Curtiss, 1994). A reasonable explanation for this circumstance is that the
pathogen primarily affected the host has weakened the immune response and created an
accessible entrance for the secondary pathogen invasion (Mallia et al., 2012). Other than that,
some drugs used to treat the primary infection potentially influence the immune cells to be less
effective in killing the pathogen. Moreover, the drug treatment will change the host's microflora,
consequently influencing the immune regulation, therefore weakening the defense to the
secondary infection (Mallia et al., 2012; Zhang and Chen, 2019).
Colibacillosis caused by APEC is characterized by death or localized inflammation in
multiple organs, which is a complex syndrome that includes (Kawano et al., 2006):
a. Airsacculitis:
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The airsacculitis is a lower respiratory infection disease in chickens, defined as
inflammation of one or more of the air sacs. The inflammation of air sacs makes them become
thicken and accumulate purulent that inhibit the breath.
b. Colisepticemia:
It is also known as blood poisoning caused by the invasion of APEC into the chicken’s
bloodstream. Once APEC spread throughout the whole body via the blood, it will be seriously
associated with multiple clinical signs of sickness.
c. Reproductive tract infection:
The oviduct infection can result in yolks laid outside the oviduct, which may lead to yolk
peritonitis in layers and breeder hens (Olsen et al., 2016).
d. Pericarditis:
The pericarditis is an inflammation of the pericardium and an accumulation of fluid or
exudates within the pericardium.
e. Perihepatitis:
Perihepatitis is an inflammation of the serous or peritoneal coating of the liver.
f. Swollen head syndrome:
The swollen head syndrome is an acute, upper respiratory tract infection associated with
APEC and viruses (Georgiades et al., 2001)
Controlling APEC infection is important in deducing poultry colibacillosis. Besides, the
elimination of predisposing factors also plays an important role, such as vaccination for birds
against the virus infection; deeply cleaning the farm facilities and poultry houses to reduce the
exposure to APEC; ensure proper ventilation of the chicken house to minimize dust and
ammonia levels and improve the air quality; strictly supervise the feed and drinking water.
7

Economic burden of APEC in the poultry industry
Colibacillosis is one of the leading causes of poultry mortality and morbidity in poultry,
and it is also one of the most commonly reported bacterial infection diseases. In Europe, the
weekly mortality rate of colibacillosis in layer flocks was reported to have reached 1.71%, and
the maximum cumulative mortality reached 9.19% (Vandekerchove et al., 2004). However, to
date, there are no studies or surveys that accurately define the specific amount of the economic
significance of colibacillosis to the poultry industry. Annual losses for the poultry industry due to
the high rates of mortality and morbidity and a wide variety of extraintestinal organ infections
caused by APEC creates a loss of production. Besides, low feed conversion rates, high medical
treatment costs, chicken health and welfare care, and labor costs also add to economic losses
(Rodriguez-Siek et al., 2005a).
Virulence of APEC
Non-pathogenic E. coli is typically distributed throughout the poultry intestinal
microflora without causing damage to health issues. However, the APEC is known to possess
various virulence factors commonly carried by plasmids; the combinations of these factors
increase the pathogenicity of APEC to the poultry. As the virulence traits of APEC attribute to
disease, and the specific virulence factor must be identified. The main factors of APEC virulence
are:
a. Adhesion
Adhesion to the epithelium is the first step of APEC infection (Ramírez et al., 2009).
Type 1 fimbriae, which is an external structure of APEC strains play a role in adhesion and
localization to the trachea, intestinal, and lung epithelial cells (Bahrani-Mougeot et al., 2002;
Boudeau et al., 2001; Dozois et al., 1994; Edelman et al., 2003). The virulence genes encoding
8

the type 1 fimbriae include fimA (fimbrial subunit gene), fimB and fimE (fimbria expressed and
fimbria repressed), fimC (chaperone), fimD (usher), fimF, fimG, fimH (minor subunits), and fimI
(fimbria-like protein) (Khan et al., 2007; Klemm, 1986; Nereus W. Gunther IV, 2002).
b. Invasion
Invasion is associated with the adhesion function, the APEC breaks the epithelial barrier
to enter the bloodstream, then expand to more extraintestinal organs and cause disease to the
host. A study conducted by Ramírez et al. (2009) showed that the APEC was able to invade
avian tracheal epithelium cells in vitro. Gene tia (invasion determinant protein), ibeA, and ibeB
have been proven to be involved in invasion and pathogenicity (Germon et al., 2005; Helmy et
al., 2018; Wang et al., 2012).
c. Iron acquisition
Iron is essential for E. coli survival; it enables some cellular activities, including electron
transport and nucleotides biosynthesis. Low iron concentration will inhibit the functions of some
strains. However, the APEC develop the strategies for survival, even in the low iron
concentration environment (Braun, 2001). The expression of the APEC iron acquisition genes
allows this pathogen to survive and grow in such conditions, especially inside the extraintestinal
organs. Part of the iron uptake genes, including iroN (chelation of iron in the host), irp2 (ironrepressible protein), iutA (iron uptake transport), and iuc (aerobactin biosynthesis) can help the
APEC achieve this function (Dho and Lafont, 1984).
d. Serum resistance
The serum consists of proteins; most of the proteins are pre-activated enzymatic forms
that defend from bacterial infections (Bugla-Płoskońska et al., 2009). Serum resistance is one of
the major virulence factors of pathogens associated with bacteremia (Miajlovic and Smith,
9

2014). Serum resistance is also a vital virulence mechanism of APEC, and it plays a significant
role in the pathogenesis of avian colibacillosis, causing septicemia in poultry. The most related
encoding gene is iss (Mellata et al., 2003).
e. Toxins
Other virulence factors that have been implicated in promoting extraintestinal diseases by
APEC strains are toxins. Toxins contribute to the infections mainly by damaging the host tissue
cells (Rudkin et al., 2017). Some toxins produced by the pathogenic E. coli are very stable and
resistant to harsh environmental conditions with extreme temperatures and pH (Miyamoto et al.,
2009). The toxins found from APEC include enterotoxin, heat-stable toxin, hemolysin, and
Shiga-like toxin. Their associated encoding genes are set1, let, ast, hly, stx (Parreira and Gyles,
2003).
Potential zoonotic risk of APEC
APEC is the pathogen generally associated with avian colibacillosis. However, with the
development of molecular technology, more common traits among APEC and human
extraintestinal pathogenic E. coli (ExPEC) strains have been revealed. It has been assumed that
APEC may become a potential risk of threat to human health (Ewers et al., 2007). In some
studies, researchers have reported that APEC serves as a reservoir of virulence and resistance
genes that threaten food safety and therefore, may cause foodborne diseases in humans (Maluta
et al., 2014).
Some characteristics of these strains could be explored to investigate the relationship
between APEC and human ExPEC, such as serogroups, virulence genotypes, and phylogenetic
groups. Some studies have compared APEC features with human ExPEC, including
uropathogenic E. coli (UPEC) and newborn meningitis-causing E. coli (NMEC). The serotypes
10

O2, O6, O7, and O25 are shared in both APEC and ExPEC. The phylogenetic group A, B1, B2,
and D are commonly overlapping between APEC and ExPEC, although the frequency of each E.
coli subtype is different (Ewers et al., 2007; Rodriguez-Siek et al., 2005a). A substantial number
of virulence genes are also included in both APEC and ExPEC, such as pTJ100-related gene
iroN, iss, iutA, adhesin genes focG, papA, papC, iron-related genes fyuA, ireA, irp-2, and toxins
genes cdtB, cnf-1, hlyD (Rodriguez-Siek et al., 2005b).
These previous works have proved that some APEC and human ExPEC harbor
overlapping characteristics, the zoonotic potential of APEC need to be further verified.
Antimicrobial resistance of APEC
Poultry cannot recover by themselves from APEC infection; once colibacillosis is
present, antimicrobial treatment is necessary to reduce economic losses and maintain animal
welfare (Dheilly et al., 2011). Frequently used antibiotics for colibacillosis treatment include
enrofloxacin, apramycin, ceftiofur, neomycin, gentamicin, amoxicillin/clavulanic acid,
trimethoprim/sulphonamide, oxytetracycline, and colistin (Chauvin et al., 2005; Luppi, 2017).
The antibiotics are normally given orally through the drinking water.
Antibiotics have been used by the poultry industry as sub-therapeutic antibiotic growth
promoters (AGPs) to improve feed efficiency and growth performance and reduce enteric
pathogens such as Clostridium and Salmonella (Danzeisen et al., 2011). The use of antibiotics as
AGPs in poultry feeds has been permitted worldwide for decades (Aarestrup, 2005). The APGs
commonly used in North America for broilers include avilamycin, tetracycline, bacitracin
methylene disalicylate (BMD), bacitracin, tylosin, salinomycin, virginiamycin, enramycin,
monensin, and penicillin (Danzeisen et al., 2015) (Mehdi et al., 2018).
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There are different mechanisms of actions by which antibiotics impact the bacteria. The
β-lactam antibiotics such as penicillin interfere with bacteria cell wall synthesis, which results in
changes to cell shape and size, induce cellular stress responses, and culminate in cell lysis
(Tomasz, 1979). The quinolone class of antibiotics kills the bacteria by interfering with the
synthesis of bacterial DNA (Zhao et al., 1997). Tetracyclines work by inhibiting bacterial protein
synthesis (Hierowski, 1965). Moreover, aminoglycosides impact protein synthesis at the cell
membrane, thereby increasing cellular permeability, killing the bacteria by increased access to
the drug molecule (Davis et al., 1986).
However, antibiotics are no longer an appropriate strategy due to the emergence of
multidrug resistance APEC strains worldwide. In Egypt, all APEC isolates from colibacillosis
broilers have been found to be resistant to ampicillin, tetracycline, spectinomycin, streptomycin,
kanamycin, and trimethoprim/sulfamethoxazole (Ahmed et al., 2013). Similarly, up to 94% of
multidrug resistance strains with the resistance patterns to ampicillin, amikacin, nitrofurantoin,
ciprofloxacin, levofloxacin, gentamicin, co-trimoxazole, doxycycline hydrochloride, and
colisitin have been detected from colibacillosis suspected broiler chickens in Nepal (Subedi et
al., 2018). A high prevalence of multidrug resistance APEC has also been detected in China
(Zhuge et al., 2019).
The antibiotic resistance genes (ARGs) carried by the strains could direct the function
that helps the bacteria survive in harsh environments. The plasmids of bacteria also serve as a
vehicle to transfer the resistance gene among strains, which increases the possibility of horizontal
transmission of antibiotic resistance (Bennett, 2008).

12

Probiotics as a potential alternative to antibiotics
Because of the widespread antibiotic resistance to poultry pathogens, researchers are
trying to find antibiotic alternatives to replace or reduce antibiotic use in the poultry industry. To
date, many strategies have been applied to the nutrient and feed alternative side of the poultry
industries, such as organic acids, enzymes, prebiotics, and probiotics (Gadde et al., 2017;
Lillehoj et al., 2018). Probiotics are considered a promising antibiotic alternative because it is
safe to the host without pathogenicity. Moreover, there is no chemical residue in poultry meat,
which is safe for both poultry and consumers (Khan and Naz, 2013). The probiotics prevent the
disease by improving the host immune ability (Kabir et al., 2004), reducing the enteritis effects,
and reducing the intestine's pathogenic bacteria.
Various probiotics have been used in poultry, including Bacillus, Bifidobacterium spp.,
Lactobacillus spp., Streptococcus, and Lactococcus spp. (Gadde et al., 2017; Griggs and Jacob,
2005; Patterson and Burkholder, 2003). Some extensive studies have confirmed their excellent
adherence ability to the host’s gut, and they can reproduce to regulate the microbiota. They are
able to survive in the birds’ gastrointestinal tract and adapt to the acidic pH environment.
Probiotics bacteria have also shown improvements in immunity, performance, and disease
prevention (Azad et al., 2018).
In order to develop antibiotic alternatives, understanding of the mechanisms of probiotics
is necessary. Even though there are no clear clarifications on how the probiotics are working,
researchers have proposed the following rationales by concluding many studies:
a.

Altering the gut microflora by occupying binding sites. Probiotics adhere and

colonize on the epithelium surface, enhance the integrity of the intestinal barrier. Probiotics

13

compete against the pathogens for the receptors and binding sites; they will block or inhibit the
binding of pathogenic bacteria to the receptors (Sun et al., 2007).
b.

The metabolites produced by probiotics inhibit the growth and reproduction of

intestinal pathogens. The production of metabolites, such as short-chain fatty acids (SCFA) and
lactic acid cell walls, the accumulation of acid, could reduce the intestinal pH, which may inhibit
the growth of pathogens (De Keersmaecker et al., 2006).
c.

Probiotics compete for nutrients with pathogens (Gourbeyre et al., 2011).

d.

Immune regulation. Probiotics may stimulate the immune system and regulate the

innate and adaptive response (Delcenserie et al., 2008).
Lactobacillus in poultry health promotion and disease prevention
Lactobacillus is a Gram-positive, aerotolerant anaerobic or microaerophilic, rod-shaped,
non-spore-forming organisms. With time, more and more studies investigating different
Lactobacillus species as probiotics, such as Lactobacillus animalis, Lactobacillus reuteri, and
Lactobacillus rhamnosus have been conducted. Studies have identified that Lactobacillus can
promote bird health by improving layers’ feed conversion ratios, body weight gain, and egg
weight (Davis and Anderson, 2002). It has also been proven that Lactobacillus can inhibit the
growth of Campylobacter jejuni in broilers (Chaveerach et al., 2002; Stern et al., 2006), so that
reduce the possibility of transmitting to the environment and affect other hosts. An apparent
effect on disease prevention of Lactobacillus against necrotic enteritis has been reported by La
Ragione et al. (2004), the Lactobacillus working by reducing the Clostridium perfringens
colonization in the intestinal tract of challenged chickens. The Lactobacillus was proved both
benefits for the growth performance and effect for disease prevention, which is a potential
alternative to antibiotics.
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Whole-genome Sequencing (WGS)
Introduction of WGS
Whole-genome sequencing is a technology to analyze the entire genome of an organism.
This technology can be used for any species, such as humans, animals, livestock, plants, and
microorganisms. The genomic information can help scientists understand the species evolution,
drug response of the organism, the virulence or antimicrobial resistance of the microorganism,
and provide a clue for treatment development (Van El et al., 2013).
In recent years, with the development of WGS technology, efficiency and throughput
have dramatically improved. At the same time, the cost has significantly decreased. The
sequencing technology evolution started from the “first-generation” approach Sanger
sequencing, which is also called the “chain termination method” The advantages of Sanger
sequencing is high accuracy and low cost, which is still widely used nowadays. Following, the
“next-generation” sequencing, which is also known as high-throughput sequencing, and the
sequencing process is faster and cheaper than the previously used Sanger sequencing. Illumina
sequencing technology is one of the “next-generation” sequencing; the basic working principle is
sequencing by synthesis. The advantage of Illumina sequencing is high throughput and high
accuracy; however, this method requires the high quality of DNA sample preparation, and it can
only provide a short read of genome pieces, which is a challenge for genome assembly. In recent
years, Nanopore sequencing is known as the “third-generation” sequencing. It has been improved
with the reading length for assembly, and it requires an easier sample preparation than the
previous generation. This technology makes the WGS of organisms accessible and affordable
(Pfeifer and Hainaut, 2011; Rusk, 2009; Schadt et al., 2010). However, the latest generation is
not perfect; the long read sequence often shows a high error rate due to the mismatch, insertion,
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or deletion of the nucleotides. The development of WGS technology is an ongoing process; the
improvement is achieved from generation to generation.
Advantages of WGS for developing pathogen control
The WGS technique applied to pathogens accomplishes the pathogen source tracking and
rapid identification and characterization of the strain. The whole-genome information is further
analyzed via information technology (IT) and bioinformatics aspects, which help in detecting
mutations of the bacteria strain and inference of the antimicrobial resistance and virulence
properties (Deurenberg et al., 2017). A full understanding of the antimicrobial resistance and
virulence properties could help direct the proper use of the drug for pathogen outbreak control.
With the development of WGS technology, more and more data contribute to the GeneBank
database, which provides a robust foundation for more organism genome research.
Campylobacter in Poultry
Introduction of Campylobacter
The genus Campylobacter means “a curved rod,” which is Gram-negative, spiral, or rodshaped, non-spore-forming bacteria. For best growth a temperature of 42 °C, in a microaerobic
atmosphere of (5% (v/v) of oxygen, 10% (v/v) of carbon dioxide, and 85% (v/v) nitrogen) is
required. Poultry is a main reservoir of Campylobacter, especially in chicken, because their body
temperature provides the best temperature for growth at nearly 42 °C (Skarp et al., 2016).
Campylobacter has been found to colonize the intestinal tract at a concentration as high as 107
CFU/g (Bryan and Doyle, 1995).
In the genus Campylobacter, the number of species has dramatically increased in recent
years; forty-seven species and 16 subspecies have been identified as of September 2020
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(http://www.bacterio.net/campylobacter.html, last accessed September 2020). Campylobacter
jejuni is the main Campylobacter species. Among the human enteric infection cases,
Campylobacter jejuni accounts for 80 to 85%. Followed by Campylobacter coli, which ranks
second, accounting for 10% to 15% of the cases (Luechtefeld et al., 1980). Other species like
Campylobacter lari, Campylobacter concisus, and Campylobacter upsaliensis are also found
closely associated with human campylobacteriosis. Most of the Campylobacter species can be
found in poultry products and food animals (Nielsen et al., 2006).
Human Campylobacter infection
Campylobacter is the leading foodborne pathogen causing gastroenteritis worldwide.
Especially in developing countries, children are at high risk of being infected (Bonner et al.,
2001). Campylobacter infections are known as campylobacteriosis. There are an estimated 1.5
million human campylobacteriosis cases in the United States annually (Foodborne Diseases
Active Surveillance Network, 2019). Symptoms appear 1 to 5 days after infections which include
headache, fever, bloody diarrhea, and vomiting (Hassanzadeh and Motamedifar, 2007)
Campylobacter jejuni infections can lead to an autoimmune condition known as GuillainBarré syndrome (GBS). Approximately 3 out of every 10,000 campylobacteriosis patients will
be diagnosed with GBS (Scallan et al., 2015). Guillain-Barré syndrome is characterized by a
neurologic disorder, with nerve-innervated muscles and weak limbs (De Vries et al., 2010). This
syndrome brings a severe economic burden on society; the cost includes medical treatment and
the loss of productivity, which means no income for the patients. There is an estimated $ 1.7
billion economic cost associated with GBS in the United States every year, with a $ 318,966
average cost for each patient (Frenzen, 2008).
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Campylobacter infection in poultry
Campylobacter spp. have been found to cause veterinary diseases, which lead to diarrhea
in cattle and sheep. A new emerging disease called spotty liver disease (SLD) has been
distributed to Campylobacter in layers in recent years. Before this discovery, chickens were
considered only be carriers of the Campylobacter spp. However, Campylobacter hepaticus has
been identified as the primary infection source for SLD (Gregory et al., 2018). SLD most
commonly occurs in free-ranging layers and is associated with lesions on the liver. It reduces egg
production by 10 to 25% and increases the mortality rate by 10% (Crawshaw and Irvine, 2012).
The transmission route of Campylobacter hepaticus was observed to be a fecal-oral route (Phung
et al., 2019). Up to now, the typical therapy method for SLD is antibiotic treatment.
Campylobacter transmission via poultry and poultry product
Campylobacter mostly colonizes poultry's intestinal tract, which provides the bacteria
with optimal growth conditions and temperatures. They easily access the farm environment
through the feces and spread among the poultry flocks by litter, feed, or water. It also suspects to
infect farmworkers in this manner (Berndtson et al., 1996). Campylobacter contamination can
also occur in the processing plant. The crates that transport poultry are moved by truck and are
reused multiple times; this transport method increases the chances for cross-contamination. The
contamination of feathers, gut removal, and the chilling process has all been shown to increase
the Campylobacter on carcasses (Genigeorgis et al., 1986). Research has reported that more than
half of the chicken carcasses processes were contaminated with Campylobacter after processing
(Franchin et al., 2007). Poultry meat and poultry products are the major vehicles that transfer
Campylobacter to humans. The consumption of raw or undercooked chicken meat is a leading
cause of human enteric illness.
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Antibiotic resistance of Campylobacter
Although most of the Campylobacter infection is self-limiting, people with severe
symptoms still need antibiotic therapy. The antibiotics commonly used as human
campylobacteriosis treatments are erythromycin, quinolones, and azithromycin (Altekruse et al.,
1999). For Campylobacter infection related to poultry, chlortetracycline, and lincospectin are
antibiotics considered effective (https://bit.ly/36kdBfy). However, long-term use of antibiotics as
therapy in both humans and poultry, as well as the growth promoter used in poultry, leads to
antibiotic resistance of the Campylobacter strains. Studies have shown Campylobacter isolates
can become highly resistant to ampicillin, penicillin, fluoroquinolone, and tetracycline
(Luangtongkum et al., 2009). Therefore, more efficient antibiotic alternatives need to be
explored. At the same time, higher standards of farm biosecurity and poultry product safety
should be taken into consideration.
Many studies have reported the significant challenge of poultry colibacillosis and human
campylobacteriosis caused by antimicrobial resistance APEC and Campylobacter, respectively.
However, few effective antimicrobial alternative control methods exist now. Due to the
insufficient knowledge of the antimicrobial properties and associated mechanisms of the
prevalent pathogens, the development of control methods is difficult to move forward. As a
result, comparative research is necessary to investigate the current prevalence status of these
pathogens and explore their antimicrobial resistance properties to help develop antimicrobial
alternative control treatments. Therefore, the objectives of this research were: (1) evaluating the
effects of in ovo inoculation with probiotics on the incidence of APEC in broilers and
investigating the virulence and antimicrobial resistance properties of the isolated APEC strains;
(2) using the whole genome sequencing technology to explore the complete genome information
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of the multi-drug resistant APEC strain, exploring the relationship of antimicrobial resistance
genotype and phenotype and revealing the full virulence gene list; (3) investigating the
prevalence of Campylobacter in the Mississippi broilers, exploring the antibiotic resistance
properties of the Campylobacter isolates, and testing the motility performance associated with
pathogenicity.
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CHAPTER II
EFFECTS OF IN OVO PROBIOTIC ADMINISTRATION ON THE INCIDENCE OF AVIAN
PATHOGENIC ESCHERICHIA COLI (APEC) IN BROILERS AND AN EVALUATION OF
THE VIRULENCE AND ANTIMICROBIAL RESISTANCE PROPERTIES OF APEC
Abstract
Avian pathogenic Escherichia coli (APEC) causes colibacillosis in poultry, which has
been traditionally controlled by the prophylactic in-feed supplementation of antibiotics.
However, antibiotics are being removed from poultry diets due to the emergence of multidrugresistant (MDR) bacteria. Therefore, alternatives to control APEC are required. This study aimed
to evaluate the effects of in ovo inoculation of probiotics on the incidence of APEC in broilers
and evaluate the virulence and antimicrobial resistance properties of the APEC isolates. On
embryonic day 18, four in ovo treatments (T) were applied: T1 = Marek’s vaccine (MV), T2 =
MV + Lactobacillus animalis, T3 = MV + L. reuteri, and T4 = MV + L. rhamnosus. A total of
180 male broilers/treatment were randomly placed in 10 pens. Heart, liver, spleen, and yolk sac
were collected on days 0, 14, 28, and 42. Presumptive E. coli isolates were confirmed by E. coli
specific real-time PCR. The positive isolates were screened for the APEC related genes (iroN,
ompT, hlyF, iss, and iutA). E. coli isolates containing one or more of these genes were identified
as APEC-like strains. A total of 144 (26.3%) APEC-like isolates were isolated from 548 organ
samples. No differences (P > 0.05) among treatments were observed for the incidence of APEClike strains in all organs when averaged over sampling days. However, when averaged over
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treatments, the incidence in the heart, liver, and yolk sac was different among sampling days; a
significant increase was observed in these organs on day 14 compared with day 0. Twenty-five
antimicrobial resistance genes were evaluated for all APEC-like isolates, 92.4% of the isolates
carried at least one antimicrobial resistance gene. Thirty-seven isolates were then selected for
antimicrobial susceptibility testing; MDR strains accounted for 37.8%. Only 29.7% of isolates
showed no resistance. In conclusion, the in ovo inoculation of a single probiotic strain did not
confer protection against APEC strains in broilers. The high prevalence of MDR isolates
indicates that further research on antibiotic alternatives is required to prevent APEC infections in
broilers.
Keywords: in ovo inoculation, Lactobacillus, multidrug-resistant, real-time PCR detection,
virulence gene
Introduction
Escherichia coli (E. coli) is a normal inhabitant in the avian gastrointestinal tract,
respiratory tract, and the surrounding environment. However, only pathogenic E. coli strains
cause disease in birds, and these strains are known as avian pathogenic E. coli (APEC). APEC
causes colibacillosis and related extraintestinal illness in poultry worldwide, which are typified
by septicemia, air sacculitis, and pericarditis (Ewers et al., 2003). The possible transmission of
APEC can occur by vertical transmission from breeders, and horizontal transmission by food, air,
litter, feces, and other birds (Nakazato et al., 2009). The gastrointestinal tract and respiratory
tract are significant routes of APEC infection, and APEC infection in poultry results in a high
mortality rate and severe economic burden for the poultry industry (Cortes et al., 2010). Besides,
APEC strains are potential zoonotic pathogens and possess a part of the same virulence genes
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with human extraintestinal pathogenic E. coli (ExPEC), which has been verified to cause disease
in mammalian infection models (Johnson et al., 2008b; Manges and Johnson, 2012).
As a therapy, antibiotics have been widely used for disease control in the modern poultry
industry against APEC. However, these antibiotics have increased the emergence and
dissemination of antibiotic resistance E. coli strains (Subedi et al., 2018; Van Den Bogaard et al.,
2001), and these resistance genes are frequently located in transferable plasmids of APEC strains
(Johnson et al., 2006). The emergence of MDR APEC not only poses difficulties to the
prevention and control of APEC infection, but also brings many challenges in creating the
potential for spread of resistance to other pathogens and commensals through mobile plasmids.
Therefore, it is essential to find an alternative approach to control APEC infection for the poultry
industry as a long-term strategy.
Probiotics are live microorganisms or preparations of microorganisms, which alter the
host's microflora, and they are intended to have health benefits for the host animals
(Schrezenmeir and de Vrese, 2001). They are the promising treatments against intestinal
pathogens because they modulate the intestinal microbiota of broiler chickens (Tarabees et al.,
2019). Probiotics provide a protective effect against pathogens by competitive exclusion of
pathogens in the gastrointestinal tract, by neutralizing enterotoxins, and stimulating the immune
system (Jin et al., 1997). Lactobacillus is a probiotic that produces lactic acid, which was
reported to have an inhibitory effect against pathogenic E. coli in chickens (Watkins et al., 1982).
Therefore, the application of Lactobacillus in poultry is a promising approach to reduce APEC
colonization in the gastrointestinal tract. In-feed probiotics are commonly used in poultry;
however, they cannot produce protection in the hatchery at such an early life stage of broilers
before the feed is provided. Oral gavage is also a possible way to deliver probiotics, but the low
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efficiency and high labor cost make oral gavage challenging to operate. To overcome these
disadvantages, in ovo inoculation is very efficient, which is also easy to operate for the
administrators. The in ovo administration of probiotics could help chickens establish a protective
microbial community at an early stage of intestinal developing (Pedroso et al., 2016) and
therefore potentially protect against APEC infection even before hatching (De Oliveira et al.,
2014).
Many studies have focused on dietary probiotic supplements and in ovo nutrients.
However, limited information is available on the protective effects of in ovo administration of
probiotics against APEC prevalence in broilers. Therefore, the objective of the current study
were (1) to determine the effects of in ovo administration of Lactobacillus probiotics on the
incidence of APEC in broilers and (2) to determine the virulence and antibiotic resistance
properties of APEC isolates recovered from broiler organ samples. The antimicrobial and
virulence properties of the APEC isolates can serve as a baseline for future surveillance and
prevention studies in this region.
Materials and Methods
Probiotic strains
Lactobacillus animalis (ATCC 35046), Lactobacillus reuteri (ATCC 2837), and
Lactobacillus rhamnosus (ATCC 23272) were used in this study. MRS broth and MRS agar (BD
Difco, Franklin Lakes, NJ) were used for culturing probiotics at 37 °C for 48 h anaerobically
(Spiral Biotech Anoxomat; Norwood, MA; VWRTM International, 1535 incubator, Cornelius,
OR, USA). These strains were obtained from the American Type Culture Collection (ATCC).
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Treatments and bird management
Ross 708 fertilized eggs were purchased from a commercial breeder farm and stored in a
cooler set at 18 °C for three days. All eggs were labeled according to treatment, flat, and egg
number. Before setting, eggs were acclimated to avoid moisture on the egg surface. The flats of
eggs were set into two previously sterilized NatureForm Incubators (18 flats/incubator and 1,080
eggs total, Model NMC-1080, Jacksonville, FL, USA), with each incubator carrying 18 flats of
eggs. Dry and wet bulb temperatures were set at 37.5 °C ± 0.1 and 28.9 °C ± 0.1, respectively on
both incubators. After 12 d of incubation, eggs were candled to discard eggs that presented as
infertile, cracked, contaminated, or early dead embryos.
On day 18 of incubation, the treatments were applied as follows: treatment 1: Marek’s
disease vaccine (HVT) alone (MV); treatment 2: MV and Lactobacillus animals (~106 CFU/50
µL per egg); treatment 3: MV and Lactobacillus reuteri (~106 CFU/50 µL per egg); and
treatment 4: MV and Lactobacillus rhamnosus (~106 CFU/50 µL per egg). On day 18 of
incubation, the 4 treatments were applied using commercial Inovoject® equipment (Zoetis,
Parsippany, NJ). The eggs were then transferred into hatching baskets (18 baskets/treatment, 6
baskets/ hatcher) distributed among three Georgia Quail Farm® hatcher units (3 for each
treatment, 12 total GQF MFG, 1502 Digital Sportsman incubator; Savannah, GA) until day 21 of
incubation (day of hatch). The hatcher’s dry and wet bulb temperatures were set at 36.9 °C ± 0.1
and 30 °C ± 0.1, respectively. On day 21, no differences were detected in hatch of fertile among
treatments inoculated. The chicks were sexed by feather discrimination, and 18 male chicks were
placed in each pen according to treatment (10 pens/treatment) in a grow-out research facility
where they were raised through a 42-day grow-out cycle.
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Sample collection
Heart, liver, and spleen samples were collected on days 0, 14, 28, and 42. Yolk sac
samples were collected on days 0 and 14 because after day 14, the yolk is generally absorbed
through the yolk stalk duct in most birds (Buhr et al., 2006). On each sampling day, one bird was
randomly picked from each pen for a total of 10 birds from each treatment. Organ samples were
transferred aseptically to prelabeled sterilized Whirl-Pak filter Bags and kept on ice until further
processing.
All animals in this trial were treated in compliance with the Guide for the Care and Uses
of Agriculture Animals in Research and Teaching (Federation of Animal Science Societies,
2010) and the Mississippi State University Institutional Animal Care and Use Committee
(IACUC Animal Welfare Assurance #A3160-01).
Bacterial isolation
Homogenized samples were first enriched in 20 mL of Tryptic Soy Broth (TSB) (BD
Bacto, Franklin Lakes, NJ) aerobically for 18-24 hours at 37 °C. Following incubation, a loopful
of the enrichment broth was streaked onto MacConkey agar (BD Difco, Franklin Lakes, NJ) and
incubated at 37 ˚C for 18 to 24 h. A single suspect colony on MacConkey agar was selected to be
suspended in Luria-Bertani (LB) broth (BD Difco, Franklin Lakes, NJ) and aerobically incubated
in a shaker incubator at 150 rpm and 37 °C for 18 h. All organisms were stored at -80 °C in LB
broth with 20% (vol/vol) glycerol until use.
Bacterial DNA preparation
DNA was prepared using boiled lysates as previously described (Mohamed et al., 2018).
Briefly, 200 µL of overnight bacteria culture was transferred into a PCR tube and centrifuged to
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obtain the bacteria pellet. The supernatant was discarded and 150 µL of nuclease-free water was
added and mixed well with a vortex. The bacteria culture was boiled at 95 °C for 5 minutes. The
resulting solution was centrifuged, and the supernatant was transferred into a new tube and
served as the DNA template. The DNA template was stored at -20 °C until further use.
Identification of E. coli
A real-time PCR assay was performed for E. coli to detect core genomic gene encoding
ybbW (Walker et al., 2017). Each reaction contained 5 μL PowerUp SYBR Green Master Mix
(Life Technologies, Carlsbad, CA), 3.5 μL nuclease-free water, and 0.25 μL each of the forward
and reverse primer (10 μM), and 1 μL of template DNA. Primers are listed in Table 2.1. Realtime PCR was performed using a QuantStudio 3 (Applied Biosystems, Foster City, CA) with the
following condition: the initial denature step was 95 °C for 20 s, 40 cycles at 95 °C for 3 s and
60 °C for 20 s. Melting curve analysis was performed in the range of 60 °C to 95 °C, 0.5 °C per
5 s increments to analyze the specificity of the primers.
Screening of APEC virulence genes by multiplex PCR
The confirmed E. coli isolates were then analyzed using pentaplex PCR as described by
Johnson et al. (2008) for the minimal predictors of APEC virulence; iroN, ompT, hlyF, iss, and
iutA genes. Primers used for pentaplex PCR are listed in Table 2.1. To eliminate the inhibition
factor of the PCR, 0.1% of Bovine serum albumin (BSA) was added in the master mix of the
amplification system (Kreader, 1996). The initial denature step was 95 °C for 2 min, cycling
parameters were as follows: 25 cycles of 95 °C for 30 s, 55 °C for 30 s and 68 °C for 3 min, and
an extension step at 72 °C for 10 min.
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All PCR products were analyzed by gel electrophoresis using a 2% agarose gel stained
with SYBR Safe DNA Gel Stain (Invitrogen, Carlsbad, CA). The results were visualized under
UV light using the Kodak Gel Logic 200 Imaging System (Eastman Kodak Co., Rochester, NY).
PCR screening and DNA sequencing for resistance genes
The APEC-like positive isolates were examined by PCR for 14 antimicrobial resistance
genes conferring resistance to β-Lactamase (blaTEM), aminoglycoside [aac(3)-VIa, aac(3)-VIb,
aph(3')-Ia, and aadA], tetracycline (tetA, tetB), trimethoprim (dfr1, dfr7, and dfr17), quaternary
ammonium compounds (qacEΔ), quinolone antibiotics (qnr), sulfonamide (sul1), and integrase
(intl1) as described previously (Kim et al., 2020). In addition, 11 heavy-metal resistance genes
for conferring resistance to arsenic (arsC), mercury (merA), tellurite (terD, terF, terX, and
terY3), copper (pcoA, pcoD, and pcoE), and silver (silE, silP) were tested. Primers are listed in
Table 2.1. The PCR products were sequenced by Eurofins Genomics (Eurofins Scientific,
Louisville, KY). The DNA sequences obtained were compared to the information in the
GenBank database using the Basic Local Alignment Search Tool (BLAST) program available
through the National Center for Biotechnology Information website
(www.ncbi.nlm.nih.gov/BLAST).
Antimicrobial susceptibility testing
A total of 37 representative APEC-like isolates from different days, treatments, and
organs were selected and subjected to antimicrobial susceptibility testing using the broth
microdilution assay and the National Antimicrobial Resistance Monitoring System (NARMS)
panels (Thermo Scientific Sensititre™ NARMS Gram Negative CMV4AGNF AST Plate,
Sensititre; Trek Diagnostics, Cleveland, OH) (Kim et al., 2020). Antimicrobial susceptibility
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testing was performed for 14 antimicrobials, including amoxicillin / clavulanic acid (AUG2),
ampicillin (AMP), azithromycin (AZI), cefoxitin (FOX), ceftriaxone (AXO), chloramphenicol
(CHL), ciprofloxacin (CIP), gentamicin (GEN), meropenem (MERO), nalidixic acid (NAL),
streptomycin (STR), sulfisoxazole (FIS), tetracycline (TET), trimethoprim / sulfamethoxazole
(SXT). A periodic quality control check of the colony count was performed according to the
Sensititre™ protocol. In addition, a plate inoculated with E. coli ATCC 25922 was used for
quality assurance and incubated with every batch of the minimum inhibitory concentration
(MIC) plates. The MIC plates were read automatically on an ARIS 2X (TREK diagnostic
system). Resulting MICs were compared to inhibition breakpoints specified by CLSI (Clinical
and Laboratory Standards Institute) and NARMS (National Antimicrobial Resistance Monitoring
System) to determine resistance or susceptibility to antimicrobials (Logue et al., 2012).
Breakpoints used in this study were amoxicillin / clavulanic acid ≥32/16 μg/mL;
ampicillin ≥32 μg/mL; azithromycin ≥32 μg/mL; cefoxitin≥32 μg/mL; ceftriaxone ≥4
μg/mL; chloramphenicol ≥32 μg/mL; ciprofloxacin ≥4 μg/mL; gentamicin ≥16 μg/mL;
meropenem ≥4 μg/mL; nalidixic acid ≥32 μg/mL; streptomycin ≥64 μg/mL; sulfisoxazole ≥
512 μg/mL; tetracycline ≥16 μg/mL; and trimethoprim / sulfamethoxazole ≥4/76 μg/mL.
(Logue et al., 2012; Whitehouse et al., 2018).
Experiment design and data analysis
The incidence of APEC-like strains was determined based on the number of samples
considered positive after PCR confirmation. The prevalence of antimicrobial-resistance
phenotypes was calculated based on the number of isolates exhibiting resistance to the
antimicrobial in proportion to the total number of APEC-like isolates. The incidence of APEC37

like strains was analyzed as a split-plot in time design with probiotic treatment as the main plot
and sampling time as the subplot. Data were analyzed using the PROC GLIMMIX procedure of
SAS 9.4 software (Institute Inc., Cary, NC), with the LSMEANS statement. Differences were
considered significant when P–value less than 0.05.
Results
Effects of probiotic administration on the incidence of avian pathogenic Escherichia coli
(APEC) in broilers
Growth of E. coli on MacConkey agar plates as confirmed by real-time PCR identification
was observed in 39.0% (214 out of 548) of the samples. Using the criteria described by Johnson
et al., (2008), we differentiated 144 APEC-like isolates (26.3%) from 548 samples, seventy E.
coli isolates (12.8%) carried none of the tested virulence traits. The virulence genes identified by
pentaplex PCR were iroN (87 isolates, 15.9%), iss (89 isolates, 16.2%), ompT (144 isolates,
26.3%), hlyF (144 isolates, 26.3%) and iutA (70 isolates, 12.8%). Table 2.2 shows that 15
isolates (2.7%) were positive for 5 genes, 72 isolates (13.1%) were positive for 4 genes (iutA,
hlyF, iroN, iss and ompT) and 2 isolates (0.4%) were positive for 4 genes with another
combination (iss, ompT, hlyF, iutA). The ompT, hlyF, iutA combination was present in 53
isolates (9.7%). The ompT and hlyF combination was present in 2 isolates (0.4%).
In ovo administration of different individual probiotic species did not significantly affect
the incidence of APEC-like strains in broiler chickens. Table 2.3 shows that there were no
differences (P > 0.05) among the four treatments for the presence of APEC-like strains in any of
the organs when averaged over sampling days. When averaged over treatments, however, the
incidence was different among sampling days for the heart (P = 0.0003), liver (P < 0.0001), and
yolk sac (P = 0.015) In the heart, the incidence of APEC was the highest on day 14 when
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compared to days 0 and 42. APEC on Day 28 was also found to be higher than day 0 but was not
different than day 42; however, the APEC incidence number did decrease from day 14 to day 42.
In the spleen, 35% of APEC-like strains were detected on day 14 and day 28, but none was
detected on day 0. On day 42, the incidence slightly decreased to 25% but was not significantly
different (P = 0.747). In the liver, the incidence of APEC-like strains on day 14 (57.5%) was
significantly higher than day 0 (5.0%), day 28 (20.0%), and day 42 (22.5%) (P < 0.0001). In the
yolk sac, APEC-like positive strains were detected in 39.3% of birds sampled on day 14, which
was greater (P = 0.015) than day 0 (15.0%).
Antimicrobial resistance genes detection
Table 2.4 shows the results of antimicrobial resistance genes identified by PCR screening
and DNA sequencing of all the APEC-like isolates. The β-lactamase encoding gene blaTEM was
detected in 16 (11.1%) APEC-like isolates, which confers resistance to β-lactam antibiotics such
as ampicillin, cephalothin, amoxicillin, and clavulanic acid. Four types of plasmid-encoded
aminoglycoside-modifying enzyme genes were examined, and aac(3)-VIa (24 isolates, 16.7%)
was the most prevalent one, followed by aac(3)-VIb (21 isolates, 14.6%), aadA (21 isolates,
14.6%), and aph(3')-Ia (19 isolates, 13.2%). Among which, gene aac(3)-VIb showed a lower
trend (P = 0.052) distributed in the isolates from treatment 1 (8.1%) and treatment 4 (3.3%)
compare with treatment 2 (26.8%). Tetracycline efflux genes were detected in 66 (45.8%)
APEC-like isolates as follows: tetA (55 isolates, 38.2%) and tetB (11 isolates, 7.6%). The
trimethoprim resistance genes were detected in 59 isolates (41.0%); dfr7 was the most common
type, as it was detected in 51 isolates (35.4%), followed by dfr1 in 8 isolates (5.6%). The
distribution of gene dfr7 in the isolates showed a lower trend (P = 0.052) in treatment 2 (29.3%)
and treatment 4 (20.0%) compared with treatment 1 (51.4%). And all isolates were negative for
39

dfr17. The quaternary ammonium compound-resistance gene qacEΔ was found in 68 isolates
(47.2%); this gene carried by the isolates from treatment 2 (65.9%) and treatment 3 (58.3%) was
significantly greater (P = 0.002) than the isolates from treatment 1 (32.4%) and treatment 4
(26.7%). The plasmid-borne quinolone resistance gene qnr was detected in 47 isolates (32.6%).
The sulfonamide resistance gene sul1 was detected in 21 isolates (14.6%).
Of all the tested heavy-metal resistance genes, arsC and merA genes were the most
abundant in APEC-like isolates, shown in Table 2.4. In particular, the arsC gene (coding for the
resistance mechanism to arsenic) was detected in 137 isolates (95.1%). The mercury resistance
gene merA was found in 29 isolates (20.1%). The tellurite resistance genes terD, terF, terX and
terY3 were detected in 5 isolates (3.5%), 4 isolates (2.8%), 3 isolates (2.1%) and 4 isolates
(2.8%), respectively. Three types of copper resistance genes were examined, pcoE was detected
in 3 isolates (2.1%), pcoA was found in 2 isolates (1.4%) and all isolates were negative for pcoD.
Two types of silver resistance genes were tested and only 1 isolate (0.7%) was positive for silP.
However, gene intl1 was found to be distributed significantly different among the treatment
groups. The intl1 gene, coding for integrase resistance were detected from 2 out of 37 (5.4%), 17
out of 41(41.5%), 9 out of 36 (25.0%), and 1 out of 30 (3.3%) APEC-like isolates from
treatments 1, 2, 3, and 4, respectively. Therefore, significantly higher (P = 0.001) levels were
found in treatments 2 and 3 compared to treatments 1 and 4.
Antimicrobial susceptibility
A total of 37 APEC-like isolates were subjected to antimicrobial susceptibility testing using
the broth microdilution assay. The prevalence of isolates resistant to each antimicrobial are
shown in Table 2.5 as follows: tetracyclines, 62.2% (23/37); gentamicin, 45.9% (17/37);
ampicillin, 43.2% (16/37); streptomycin, 29.7% (11/37); sulfisoxazole, 29.7% (11/37);
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amoxicillin / clavulanic acid, cefoxitin and ceftriaxone, 21.6% (8/37) each; and trimethoprim /
sulfamethoxazole, 16.2% (6/37). All tested isolates were susceptible to the remaining 5
antimicrobials including azithromycin, chloramphenicol, ciprofloxacin, meropenem, and
nalidixic acid.
The antimicrobial resistance patterns of the tested APEC-like strains are shown in Table
2.6. Based on the broth microdilution results, 11 (29.7%) of the isolates were susceptible to all
14 antimicrobials tested. Twenty-six (70.2%) of the isolates showed resistance to at least one
antimicrobial, while 14 (37.8%) of the isolates demonstrated MDR to three or more different
classes of antimicrobial agents (Basak et al., 2016; Magiorakos et al., 2012). Eight isolates
(21.6%) were resistant to 8 antimicrobial agents in 6 antimicrobial classes (β-lactam combination
agents, penicillins, cephems, aminoglycosides, folate pathway antagonists, tetracyclines). Two
isolates (5.4%) were resistant to 4 antimicrobial agents in 4 antimicrobial classes (penicillins,
aminoglycosides, tetracyclines, folate pathway antagonists). Four isolates (10.8%) were resistant
to 3 antimicrobial agents in 3 classes (aminoglycosides, tetracyclines, folate pathway
antagonists). Nine isolates (24.3%) and 3 isolates (8.1%) were resistant to 2 and 1 tested
antimicrobial agents, respectively.
Discussion
In this study, one of the main purposes was to evaluate the effects of in ovo inoculation of
probiotic bacteria on the incidence of APEC in broilers. Lactobacillus animalis, Lactobacillus
reuteri, and Lactobacillus rhamnosus are three probiotics that have performed well in reducing
E. coli in animals. Lactobacillus animalis NP51 as a direct-fed antimicrobial was suggested as
effective at reducing the recovery rate of E. coli O157: H7 from cattle feces (Ayala et al., 2017).
In weanling pigs, Lactobacillus reuteri is reported to be capable of reducing the abundance of E.
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coli and their associated virulence factor, such as the heat-stable enterotoxin (Yang et al., 2015).
Additionally, Spinler et al. (2008) suggested Lactobacillus reuteri was able to produce the
bacteriocin reuterin and inhibit the growth of different enteric pathogens in vitro, including
enterohemorrhagic E. coli, and enterotoxigenic E. coli. Lactobacillus rhamnosus is also a
probiotic which was proven to be capable of lowering the translocation rates of E. coli O157: H7
in a mice model (Shu and Gill, 2002). The mechanism explored by Johnson-Henry et al. (2008)
revealed that Lactobacillus rhamnosus can reduce the injury of intestinal epithelial monolayer
barrier functions by preventing changes in host cell morphology.
From the present study, no differences were observed in the incidence of APEC-like
strains among the probiotic administered groups and control groups. This finding was
unexpected and suggested that the in ovo inoculation of Lactobacillus animalis, Lactobacillus
reuteri, and Lactobacillus rhamnosus individually cannot reduce the incidence of APEC-like
strains. A possible explanation for the results might be that single strain administration is not as
effective as a probiotic mixture of strains. Another possible reason is that the in ovo inoculation
is a one-time administration. Although it may effectively protect the birds at hatch, probiotic in
ovo inoculation may not prevent APEC as the chicks grow. Feed or water supplementation
provides continual probiotic administration (Tortuero, 1973; Watkins and Kratzer, 1984).
Dietary supplement probiotic mixes have been reported to have the capability to lower E. coli
recovery rates from the broiler liver and spleen, such as Bacillus subtilis, Clostridium butyricum,
and Lactobacillus plantarum (Tarabees et al., 2019); however, there is limited research that
evaluates the mixes of Lactobacillus animalis, Lactobacillus reuteri, and Lactobacillus
rhamnosus on reducing APEC incidence. Future work is needed to investigate the effects of the
Lactobacillus mixes on reducing APEC incidence. Furthermore, exploration of the combination
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of in ovo inoculation and feed supplementation in reducing APEC incidence should be
investigated in broilers.
The purpose of probiotic administration by in ovo inoculation is to affect intestinal flora
at an early stage of intestinal development. The amniotic fluid is swallowed by the chicken
embryo at the end of incubation (Tona et al., 2010). It has previously been observed that in ovo
inoculation of probiotics was capable of reducing Salmonella colonization from day 1 to day 7
(Hashemzadeh et al., 2010). When comparing the effect on APEC-like strains in this study, a
significantly higher prevalence was observed in the heart, liver, spleen, and yolk sac on day 14
than day 0 in all treatments. This result suggested that the probiotics did not work well to protect
against APEC-like strains during the first two weeks of the chicken’s life. When mimicking the
natural mode of APEC infection to broilers, Tawab et al. (2016) found that the initial APEC
infection usually occurs at 4-9 weeks old. This can be explained by Antao et al. (2008) in which
young broiler chickens were easily infected by the intra-tracheal pathway due to the immature
bronchus-associated lymphoid tissue in the lung within the first two months of their life. This
also suggested that APEC infection is not only from intestinal microflora. The in ovo inoculation
in this study was a one-time administration, although it effectively protects the birds at hatch, it
may not last for 14 days after hatch. Another possible reason for the lack of a treatment effect in
the current study is the virulence gene transmission among different bacteria. As birds are
exposed to the environment with numerous pathogens, horizontal transfer of some virulence
genes among E. coli and other bacteria may result in the specialization of APEC (Mora et al.,
2013). Additionally, the variation of the environmental E. coli strain also increases the infection
risk for broilers.
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One interesting finding is that on day 0, most of the organs were detected with the
presence of APEC-like strains except for the spleen. Normally, when chicks are newly hatched,
the gastrointestinal tract is expected to be sterile (Juricova et al., 2013). However, APEC strains
have been reported to enter and colonize inside the egg through vertical transmission from
breeder hens during egg development or by horizontal transmission by penetrating the outer
surface of the egg shell after egg formation (Giovanardi et al., 2005; Petersen et al., 2006).
Earlier colonization of APEC inside the embryo, well before the in ovo administration of
probiotics might be a possible reason for failure of probiotic treatments in preventing APEC
incidence.
The other aim of this study was to characterize the virulence and antimicrobial properties
of the APEC-like isolates. The virulence genes iroN, ompT, hlyF, iss, and iutA are the minimal
predictors to characterize APEC (Johnson et al., 2008a). The main functions of these genes are
iron acquisition (iroN), adhesion (ompT), hemolysis (hlyF), serum resistance (iss), and ferric
aerobactin receptor (iutA) (Mohamed et al., 2018). Adhesion and hemolysis are prerequisites for
colonization and invasion inside the host. In this study, ompT and hlyF were the most prevalent
virulence genes in the APEC-like isolates with a 100% frequency. Due to differences in APEC
sampling origin, there is no standard range of prevalence for each virulence gene. When
comparing with other research for reference, the frequency of the ompT gene in APEC strains
from poultry samples averaged from 78.6% to 94.1%, and hlyF accounted for 59.3% to 80.4%
(Ahmed et al., 2013; Jeong et al., 2012). This indicates that the APEC-like isolates of this study
may have a higher potential adhesion and hemolysis capacity. Prevalence of the gene iutA
(46.5%) was lower than the data from related research (Ahmed et al., 2013) (Mohamed et al.,
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2018), showing that the APEC-like isolates from these samples possibly produce less toxins and
siderophores than others (Sarowska et al., 2019).
It is reported that APEC shares some common virulence factors with other ExPEC, such
as human uropathogenic E. coli (UPEC) (Rodriguez-Siek et al., 2005). The serum resistance
gene iss is associated with ColV plasmids that exist in both APEC and human UPEC, and this iss
gene is more prevalent in APEC than in UPEC strains (Ewers, et al., 2007). These findings
support the idea that APEC may serve as a reservoir of virulence genes for UPEC strains, and
there is a potential zoonotic risk of APEC to spread to human beings, and that human UPEC
should be considered.
Another promising prospect in virulence gene exploration is that virulence gene
combinations may help distinguish APEC from other pathogenic E.coli, such as avian fecal E.
coli (AFEC), as described by Mohamed et al. (2018). From this study, five different combination
patterns of the virulence genes were detected among the APEC-like isolates. The virulence
profile combinations of iroN, iss, ompT, hlyF (13.1%) and ompT, hlyF, iutA (9.7%) were the
most common in this study. These results are consistent with those of Meguenni et al. (2019) and
Li et al. (2015), who found that these two combinations were of similar proportion in their study,
which accounted for 13.9% and 4.6%, respectively. Similarly, Saviolli et al. (2016) also reported
that the virulence profile combination of iroN, iss, ompT, hlyF was the most prevalent pattern
detected in 13.9% of strains. Our results also indicate that only 2.7% of APEC-like strains
possessed all five genes (iroN, iss, ompT, hlyF, and iutA), which is lower than those previously
reported (Li et al., 2015; Meguenni et al., 2019; Ahmed and Shimamoto, 2013). Li et al. (2015)
obtained a higher prevalence for all five genes from APEC isolated from broilers with
colibacillosis in China, with a prevalence of 4.6%. In Algeria, 13.9% of the APEC strains
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isolated from visceral organs (liver, lungs, heart, and spleen) of diseased broilers were positive
for all 5 APEC related genes (Meguenni et al., 2019). In Egypt, 71.4% of the APEC strains
isolated from septicemic broilers carried 5 APEC virulence genes (Ahmed and Shimamoto,
2013). Taken together, these studies support that the prevalence of virulence genes may vary
depending on the isolation source and geographic origin of the samples. The lower prevalence of
APEC-like isolates with all virulence genes in the current study as compared to APEC isolated
from clinically ill birds in other studies indicate that coexistence of these virulence genes is a
crucial factor deciding the severity of the infection.
A surprising and new finding from this research showed that the Lacobacillus rhamnosus
may affect the gene prevalence, which reduces the resistance to aminoglycoside enzymes,
trimethoprim, and integrase of the APEC-like isolates. Currently, there is not sufficient evidence
to support the viewpoint that the probiotics protect the poultry against APEC by reducing the
antimicrobial resistance genes; therefore, this might be a new perspective on controlling APEC
due to the antimicrobial resistance. Moreover, the emerging antimicrobial resistance among
different APEC-like isolates has stimulated our interest in exploring the frequencies of genetic
determinants. From all of the metal resistance genes detected in this study, the arsenic resistant
gene arsC was the most prevalent of the 9 metal resistance genes, and it was widely distributed
in 95.1% of the tested APEC-like isolates. The resistance to arsenic has been linked to the use of
arsenic-based antimicrobials in the feed of poultry for growth promotion and pathogen control
since 1994 (Chapman and Johnson, 2002; Liu et al., 2016).
In addition, the frequent dietary use of arsenic in poultry results in the accumulation of
arsenic in humans by consuming poultry products (Jones, 2007; Nachman et al., 2013; Nigra et
al., 2017). Therefore, the arsenic used in feed was banned in many countries around the world.
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The European Union was the first to cease the use of arsenicals as feed additives in 1999 (Liu et
al., 2016). In the United States, roxarsone, arsanilic acid, nitarsone, and carbarsone were banned
in food-producing animals in 2013 by the Food and Drug Administration. In China, the use of
phenylarsonic feed additives was officially banned in 2019 (Hu et al., 2019). Even so, the arsenic
resistance gene remains in the genome of these APEC isolates, which indicates the “memory” of
arsenic resistance is enduring. The high level of arsenic resistance genes in APEC isolates may
affect medical treatment when arsenic is a needed drug therapy, such as the treatment for
coccidiosis (Nachman et al., 2013).
The resistance gene qacEΔ to quaternary ammonium compounds (QACs) was the second
most prevalent in this study, which existed in 47.2% of the detected APEC-like isolates. QACs
are cationic surface-active detergents, usually used for the control of environmental bacteria or
the disinfection of facility surfaces on the farm (Ioannou et al., 2007). The gene qacED1 is a
mutant version of the gene qacE (Kazama et al., 1999), which was found in 70.6% of E. coli in
chickens with colibacillosis in Egypt (Ibrahim et al., 2019). The possible reason for the high
prevalence of the QACs resistance gene is that the QACs are of low toxicity, non-irritating to
poultry, and of good efficiency; so unlimited, longtime use has caused the bacteria to develop
resistance (Hegstad et al., 2010). Although in this study we have found QACs resistance genes to
be widespread, they are not entirely associated with antimicrobial resistance phenotypes (Jaglic
and Cervinkova, 2012). Therefore, more exploration of the gene together with resistance
mechanisms should be conducted in future research.
The tetA and tetB genes encode efﬂux mechanisms and are the most common tetracycline
resistance determinant in E. coli (Roberts, 1994; Van et al., 2008). The tetA and tetB in our
isolates were quite high (44.4%) which is consistent with that found by other authors (Sgariglia
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et al., 2019; Younis et al., 2017). These results were further supported by a study from Ibrahim et
al. (2019) carried out in Jordan and Egypt, which reported that more than 90% of the APEC
isolates from broilers carried at least one of these genes. Tetracyclines are commonly used
antimicrobials in poultry as well as in other animal species to treat infections caused by
microorganisms (Agyare et al., 2018), which could explain the high prevalence of the tetA and
tetB genes in our APEC-like isolates. When we explored the phenotype for tetracycline
resistance of these strains, the antimicrobial susceptibility results showed that up to 62.2% of the
APEC-like isolates were resistant to tetracycline. One possible reason is that there are not only
these two genes directing tetracycline resistance (Subedi et al., 2018). For example, some gramnegative bacteria carry multiple tet genes, such as E. coli O157: H7 which has at least six known
tet genes: tetA, tetB, tetC, tetD, tetE, and tetG genes. Therefore, more related genes should be
examined to explore the mechanism and relationship between the tetracycline resistance
phenotype and genotype.
From the antimicrobial susceptibility testing results, we found that these APEC-like
isolates were highly resistant to tetracycline, gentamicin, ampicillin, streptomycin, amoxicillin /
clavulanic acid, cefoxitin, ceftriaxone, and trimethoprim/sulfamethoxazole. These results are in
agreement with Merchant et al. (2012), which showed high resistance rates of tetracycline,
ampicillin, and amoxicillin-clavulanic acid in pathogenic E. coli isolates from poultry litter. In
eastern China, Xu et al. (2019) isolated APEC from infected chickens with typical lesions that
had high resistance rates to tetracycline, ampicillin, cefotaxime, chloramphenicol, gentamicin,
kanamycin, streptomycin, sulphamethoxazole-trimethoprim, and nalidixic acid. The emergence
and dissemination of multidrug-resistant bacteria have reduced the effectiveness of
antimicrobials and may pose substantial risks for human health (Mellata, 2013; Rueda Furlan,
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2019). The presence of strains resistant to antimicrobials in our study should be an alert
regarding the proper use of these antimicrobials.
Conclusion
In conclusion, inoculating Lactobacillus animalis, Lactobacillus reuteri, and
Lactobacillus rhamnosus individually using commercial in ovo technology indicated no
protection to decrease the incidence of APEC-like strains in broilers. Under the conditions of this
study, a high level of virulence genes and antimicrobial resistance genes was detected from the
isolated APEC-like strains, which is a potential threat of virulence gene transmission by plasmids
among bacteria in the poultry farm. Additionally, there is a high possibility for these strains to
develop complications during treatment. The results obtained in this study provide valuable
information to better understand the phenotypic and the molecular basis of antimicrobial
resistance in APEC, which is essential for developing effective intervention methods to control
antimicrobial resistance APEC.
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Table 2.1
Primer

Primers used for the amplification
Sequence (5’-3’)
Forward

Minimal predictors of APEC virulence genes
iroN
AATCCGGCAAAGAGACGAACCGCCT
ompT
TCATCCCGGAAGCCTCCCTCACTACTAT
hlyF
GGCCACAGTCGTTTAGGGTGCTTACC
Iss
CAGCAACCCGAACCACTTGATG
iutA
GGCTGGACATCATGGGAACTGG
Antimicrobial resistance genes
blaTEM
ATGTGCGCGGAACCCCTATTTGTTTA
aac(3)-VIa
GGCACCCGCGACGCCCTGGTCCAAAAG
aac(3)-VIb
GGGCAAGCGCCGCGTCACTTATT
aph(3’)-Ia
TCGGGCAATCAGGTGCGACAATCTA
aadA
TAACGGCGCAGTGGCGGTTTTCA
tetA
CGGGGCGACTGGGGCGGTAGC
tetB
AACGCGTGAAGTGGTTCGGTTGGT
dfr1
ATCGGGAATGGCCCTGATA
dfr17
ATATCCCGTGGTCAGTAAAAGGTG
qacEΔ
CCCTTCCGCCGTTGTCATAATCG
qnr
TCGCCGCTGCCGCTTTTATCAGT
sul1
CGCCGCTCTTAGACGCCCTGTCC
intl1
CACTCCGGCACCGCCAACTTTC
Heavy-metal resistance genes
terD
CCACTGCGCGGAATTTCCACTCACCAT
terX
ATGCGCCGCCTGCCTGTTTACCTTGTTA
terF
CCGACAAACTTCCAGAAGATGGGGTAGT
terY3
CCTGGGGCCGTCAGCGGACCTG
pcoA
ATCCGGAAGGTCAGCACCGTCCATAGAC
pcoD
GGCGCCCAGAATGATAATCGCAACA
pcoE
GTGGGGCAGCTTTTGCTCAGTCCAGTGA
arsC
ACCCGCTTCATCAACCACTT
silP
ACACCCCGGCCTGGGCTCCTT
merA
GATCCGCGCCGCCCATATCGCCCATCTG

Reverse

Size (bp)

Reference

GTTCGGGCAACCCCTGCTTTGACTTT
TAGCGTTTGCTGCACTGGCTTCTGATAC
GGCGGTTTAGGCATTCCGATACTCAG
AGCATTGCCAGAGCGGCAGAA
CGTCGGGAACGGGTAGAATCG

553
496
450
323
302

Johnson et al., 2008
Johnson et al., 2008
Johnson et al., 2008
Johnson et al., 2008
Johnson et al., 2008

AAAAAGCGGTTAGCTCCTTCGGTCCT
GGGCCCGGCGCCGATCGACAGGATTT
CGCGGCGTTGTTTCGGCTTCA
TGCCAGCGCATCAACAATATTTTCACC
AAGCTCGCCGCGTTGTTTCATCAAG
CAAAGCGCGGCCGGCACCTGT
TTCGCCCCATTTAGTGGCTATTCTTC
CTTCCGGCTCGATGTCTATTGTAG
GACCCCCGCCAGAGACATA
TACAAAGCCCCACGCATCAAGC
GCCAACAGTCGCGGGAGAAGGTG
CGCCGCTCTTAGACGCCCTGTCC
GAACGGGCATGCGGATCAGTGAG

558
502
302
378
365
372
446
328
342
175
440
462
545

Logue et al., 2017
Logue et al., 2017
Johnson et al., 2006
Logue et al., 2017
Johnson et al., 2006
Johnson et al., 2012
Logue et al., 2017
Logue et al., 2017
Logue et al., 2017
This study
Logue et al., 2017
Johnson et al., 2012
Johnson et al., 2012

ACGCCGTCCCGTCTGATGTTGACAAG
CGCGCTTGTGCTGCCGGAAGACA
GAGGCAGCGGTTGCATTTGTACTTGACG
TCCTTGCTGGTGGCCGTTCATACTTCAT
GACCTCGCGGATGTCAGTGGCTACACCT
GGGCGTGGCGCTGGCTACACTT
CGAAGCTTTCTTGCCTGCGTCTGATGTG
TGCCGATATGGGGATTTCCG
TGCGGGCACGGGAACAAACCTC
CACGCGCTCGCCGCCGTCGTTGAGTTG

231
576
428
302
507
502
385
268
603
250

Johnson et al., 2006
Johnson et al., 2006
Johnson et al., 2006
Johnson et al., 2006
Johnson et al., 2006
Johnson et al., 2006
Johnson et al., 2006
This study
Johnson et al., 2006
Johnson et al., 2012
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Table 2.2

Virulence profile of APEC isolates

Virulence profile
iroN, iss, ompT, hlyF,iutA
iroN, iss, ompT, hlyF
iss, ompT, hlyF, iutA
ompT, hlyF, iutA
ompT, hlyF
total

Number of virulence
factors present
5
4
4
3
2
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Frequency (n = 548)

Percentage

15
72
2
53
2
144

2.7%
13.1%
0.4%
9.7%
0.4%
26.3%

Table 2.3

Prevalence of APEC isolated from different organs in each treatment
Sampling organ (%)

Treatment

Heart

SEM1

Liver

SEM1

Spleen

SEM1

Yolk
sac

Marek’s
vaccine
27.5
7.10
22.5
6.31
27.5
15.10
33.3
(MV)
MV and L.
27.5
7.10
32.5
8.05
22.5
11.21
38.5
animalis
MV and L.
32.5
7.88
30.0
7.67
22.5
11.21
11.1
reuteri
MV and L.
22.5
6.21
20.0
5.80
22.5
11.21
21.1
rhamnosus
P
0.757
0.448
0.926
0.164
Day
0
5.0 c
3.39
5.0 c
3.31
0
0
15.0 b
14
52.5 a
7.94
57.5 a
7.91
35.0
7.76
39.3 a
28
35.0 ab
7.57
20.0 bc
6.28
35.0
7.76
bc
b
42
17.5
5.98
22.5
6.58
25.0
6.85
P
0.0003
<.0001
0.747
0.015
a-c
Means in a column not sharing a common superscript were different (P < 0.05)
1
SEM, Standard error of mean
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SEM1
11.97
15.80
6.81
9.20

5.37
10.50

Table 2.4

Resistance
genes
blaTEM
aac(3)-VIa
aac(3)-VIb
aph(3')-Ia
aadA
tetA
tetB
dfr1
dfr7
dfr17
qacEΔ
qnr
sul1
intl1
arsC
merA
terD
terF
terX
terY3
pcoA
pcoD
pcoE
silE
silP

Results of antimicrobial resistance gene detection

Resistance profile
β-Lactamase

Aminoglycoside

Tetracycline
Trimethoprim
Quaternary
ammonium
compounds
Quinolone
Sulfa
Integrase
Arsenic
Mercury
Tellurite

Copper
Silver

Number of
resistant
isolates (%)

Number of resistance isolates in each treatment (%)
Marek’s
vaccine
(MV)

SEM1

MV and
Lactobacillus
animal

SEM

MV and
Lactobacillus
reuter

SEM

MV and
Lactobacillus
rhamnosu

SEM

16 (11.1)
24 (16.7)
21 (14.6)
19 (13.2)
21 (14.6)
55 (38.2)
11 (7.6)
8 (5.6)
51 (35.4)
0

7 (18.9)
5 (13.5)
3 (8.1)
3 (8.1)
4 (10.8)
13 (35.1)
1 (2.7)
0
19 (51.4)
0

0.065
0.057
0.045
0.045
0.052
0.080
0.027
0
0.083
0

1 (2.4)
9 (22.0)
11 (26.8)
2 (4.9)
8 (19.5)
20 (48.8)
4 (9.8)
7 (17.1)
12 (29.3)
0

0.024
0.065
0.070
0.034
0.063
0.079
0.047
0.059
0.072
0

5 (13.9)
9 (25.0)
6 (16.7)
7 (19.4)
8 (22.2)
15 (41.7)
2 (5.6)
1 (2.8)
14 (38.9)
0

0.058
0.073
0.063
0.067
0.070
0.083
0.014
0.028
0.082
0

3 (10)
1 (3.3)
1 (3.3)
7 (23.3)
1 (3.3)
7 (23.3)
4 (2.8)
0
6 (20.0)
0

0.054
0.033
0.033
0.079
0.033
0.079
0.063
0
0.074
0

0.212
0.149
0.052
0.095
0.178
0.178
0.428
0.354
0.052
1

68(47.2)

12(32.4) b

0.078

27(65.9) a

0.075

21(58.3) a

0.083

8 (26.7) b

0.082

0.002

47 (32.6)
21 (14.6)
29 (20.1)
137 (95.1)
29 (20.1)
5 (3.5)
4 (2.8)
3 (2.1)
4 (2.8)
2 (5.4)
0
3 (2.1)
0
1 (0.7)

19 (51.4)
3 (8.1)
2 (5.4) b
36 (97.3%)
7 (18.9)
2 (5.4)
2 (5.4)
2 (5.4)
2 (5.4)
2 (1.4)
0
0
0
0

0.083
0.045
0.038
0.027
0.065
0.038
0.038
0.038
0.038
0.038
0
0
0
0

16 (39.0)
9 (22.0)
17 (41.5) a
38 (92.7)
8 (19.5)
2 (4.9)
2 (4.9)
1 (2.4)
2 (4.9)
0
0
0
0
0

0.079
0.065
0.078
0.041
0.063
0.034
0.034
0.024
0.034
0
0
0
0
0

12 (33.3)
8 (22.2)
9 (25.0) a
35 (97.2)
9 (25.0)
0
0
0
0
0
0
0
0
0

0.080
0.070
0.073
0.028
0.073
0
0
0
0
0
0
0
0
0

0
1 (3.3)
1 (3.3) b
28 (93.3)
5 (16.7)
1 (3.3)
0
0
0
0
0
3 (10.0)
0
1 (3.3)

0
0.033
0.033
0.046
0.069
0.033
0
0
0
0
0
0.056
0
0.033

0.467
0.093
0.001
0.716
0.851
0.982
0.999
0.930
0.999
0.999
1
0.999
1
0.999

a-c
1

Means in a column not sharing a common superscript were different (P < 0.05)
SEM, Standard error of mean
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P

Table 2.5

Results of antimicrobial susceptibility testing

Antibiotic agents tested

Antimicrobial class

Amoxicillin / Clavulanic acid
(AUG2)
Ampicillin (AMP)
Azithromycin (AZI)
Cefoxitin (FOX)
Ceftriaxone (AXO)
Chloramphenicol (CHL)
Ciprofloxacin (CIP)
Gentamicin (GEN)
Meropenem (MERO)
Nalidixic Acid (NAL)
Streptomycin (STR)
Sulfisoxazole (FIS)
Tetracycline (TET)
Trimethoprim / Sulfamethoxazole
(SXT)

β-lactam combination
agents
Penicillins
Macrolides
Cephems
Cephems
Phenicols
Quinolones
Aminoglycosides
Penems
Quinolones
Aminoglycosides
Folate pathway antagonists
Tetracyclines
Folate pathway antagonists
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Number of resistant strains
n = 37
8 (21.6%)
16 (43.2%)
0
8 (21.6%)
8 (21.6%)
0
0
17 (45.9%)
0
0
11 (29.7%)
11 (29.7%)
23 (62.2 %)
6 (16.2%)

Table 2.6

Antimicrobial resistance patterns of tested APEC isolates against 14 antimicrobial agents

Resistance patterna

Antimicrobial class

AUG2, AMP, FOX,
AXO, GEN, STR,
FIS, TET

β-lactam combination agents,
Penicillins, Cephems,
Aminoglycosides, Folate pathway
antagonists, Tetracyclines
Penicillins, Aminoglycosides,
Tetracyclines, Folate pathway
antagonists
Aminoglycosides, Tetracyclines,
Folate pathway antagonists
Penicillins, Tetracyclines
Penicillins, Aminoglycosides
Aminoglycosides, Tetracyclines
Aminoglycosides, Folate pathway
antagonists
Tetracyclines

AMP, STR, TET,
FIS, SXT
GEN, TET, SXT
AMP, TET
AMP, GEN
GEN, TET
GEN, STR, FIS
TET
None

No. of
No. of
antimicrobial resistant
class
isolates

None

6

8

21.6%

4

2

5.4%

3

4

10.8%

2
2
2

4
2
2

10.8%
5.4%
5.4%

2

1

2.7%

1

3
11

8.1%
29.7%

0

a

Percentage

AUG2, amoxicillin/clavulanic acid; AMP, ampicillin; FOX, cefoxitin; FIS, sulfisoxazole; AXO, ceftriaxone; GEN, gentamicin; STR, streptomycin; TET,
tetracycline; SXT, trimethoprim/sulfamethoxazole
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CHAPTER III
COMPLETE GENOME SEQUENCE OF MULTIDRUG-RESISTANT AVIAN-PATHOGENIC
ESCHERICHIA COLI STRAIN APEC-O2-MS1170
Abstract
Avian pathogenic Escherichia coli (APEC) cause colibacillosis, one of the leading
causes of mortality and morbidity associated with significant economic losses in the poultry
industry. This study aimed to determine antimicrobial resistance (AMR) and characterize the
genome sequence of a multidrug-resistant (MDR) APEC strain isolated from a broiler chicken.
The strain APEC-O2-MS1170 was isolated from the broiler yolk sac of a day 14 broiler.
Antimicrobial susceptibility testing was performed using Sensititre system panel. Whole-genome
sequencing was performed by using both the long-read sequencing approach with a Nanopore
GridION sequencer and the short-read sequencing approach with the Illumina HiSeq X-Ten
sequencer to obtain a complete scaffold of the genome and an accurate sequence. A large number
of antimicrobial resistance genes (ARGs) were identified by ResFinder 3.2, including genes
encoding resistance to aminoglycosides, β-lactams, sulphonamide, tetracycline, and an unusual
MDR gene mdf(A) that is responsible for Macrolide-Lincosamide-Streptogramin (MLS)
resistance. The genome size of strain APEC-O2-MS1170 is 4,993,909 bp with a GC content of
50.7% and 4651 protein-coding sequences. The size of chromosome and three plasmids are
4,735,839 bp, 122,104 bp, 134,406 bp, and 1,552 bp, respectively. Public databases were used to
identify virulence-associated genes (VAGs) and ARGs cargo. Plasmid comparisons showed that
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pAPEC-O2-MS1170-R is a large multidrug resistance IncB/O/K/Z plasmid while pAPEC-O2MS1170-ColV share homology with APEC ColV virulence plasmid. The genome sequence of
APEC-O2-MS1170 provides valuable information on resistance mechanisms and virulence
characteristics of pathogenic E. coli, as well as information for tracing the potential spread of this
MDR strain from poultry product to the consumers.
Keywords: avian pathogenic Escherichia coli, multidrug-resistant, whole-genome sequencing,
zoonotic potential, broiler
Introduction
Escherichia coli (E. coli) is a ubiquitous bacterium that commonly inhabits the
gastrointestinal tract of humans and most animals, including poultry species (Grauke et al.,
2002). Most strains are nonpathogenic, while virulent E. coli strains are frequently associated
with a wide range of localized and systemic diseases. Avian pathogenic E. coli (APEC) is a
subgroup of extraintestinal pathogenic E. coli (ExPEC) that cause extraintestinal infections in
poultry which are collectively known as colibacillosis, one of the leading causes of mortality and
morbidity, especially in layers and broilers, which leads to significant economic devastating to
poultry industries (Antao et al., 2008). APEC shares some common virulence factors with human
ExPEC, such as the serum resistance gene iss (Ewers et al., 2007), thus alerting to a potential
zoonotic risk that may threaten human health (Johnson et al., 2008; Manges and Johnson, 2012).
Some antimicrobial agents are used to prevent and treat colibacillosis, including
penicillins, cephalosporin, tetracycline, and fluoroquinolones (Landoni and Albarellos, 2015;
Oosterik et al., 2014). However, antimicrobial treatments produce less effective pressure due to
the development of AMR. Besides, some of the antibiotics are also used as growth promoters,
which is of a great possibility to increase the resistance (Dibner and Richards, 2005). The AMR
65

is complex associated with antimicrobial genes exist in the chromosome or plasmids, APEC can
develop resistance to antibiotics that are often carried on transferable plasmids. The emergence
of MDR APEC not only poses difficulties to the prevention and control of APEC infection but
also brings many challenges in creating the potential for the spread of resistance to other
pathogens and commensals through mobile plasmids (Agyare et al., 2018; Sarker et al., 2019).
Therefore, the spread of MDR APEC among chickens or through chicken products to humans is
a significant concern for both poultry health and food safety.
Although some of the virulence and antibiotic factors have already been addressed, the
molecular identification is not comprehensive (Li et al., 2005). Whole genome sequencing
(WGS) is a powerful approach that provides deep insights into the detailed genome information,
and rapidly identify the virulence and resistance gene properties, which also helps to explore the
associated spread routes. Many genetic similarities and differences among the tested APEC and
ExPEC strains can be clarified according to the WGS.
This study was therefore performed to determine the AMR and characterize the genome
sequence of an MDR strain APEC-O2-MS1170 isolated from the yolk sac of a 14-day old
broiler, which carried a class 1 integrase gene intI1 and showed MDR phenotype. To facilitate
understanding of resistance genotype-phenotype relationships, in this study we sequenced and
annotated the complete genome of APEC-O2-MS1170 to identify the ARG profiles. The WGS
data were further profiled against a comprehensive virulence factor database for identifying
putative VAGs.
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Material and Methods
Bacteria selection
The E. coli APEC strain APEC-O2-MS1170 was from our preliminary study, which was
isolated from the yolk sac of a 14-day old broiler in Mississippi. The strain was isolated using
MacConkey Agar and cultured with Luria-Bertani (LB) broth. The bacterial stock of APEC-O2MS1170 strain was stored at -80 °C with a final concentration of 20% (v/v) glycerol in the 2-mL
cryovial. This APEC-O2-MS1170 strain was selected because it was resistant to 8 antimicrobials
tested by Sensititre panel (Thermo Scientific Sensititre™ NARMS Gram Negative CMV4AGNF
AST Plate, Sensititre; Trek Diagnostics, Cleveland, OH, USA).
Bacterial total genomic DNA preparation
The APEC-O2-MS1170 strain was inoculated on a LB agar plate from the glycerol cell
stock stored at -80 °C and incubated at 37 °C overnight. A single colony was selected and subcultured in 1.5-mL LB broth on an orbital shaker at 37 °C/200 rpm for 18 hours. The bacterial
culture was harvested by centrifugation at 1,000 rpm for 3 min, and the cell pellet was washed
with PBS in a 1.5 mL centrifuge tube and centrifuged at 1,000 rpm for 3 min for DNA
extraction. The GeneJET Genomic DNA Purification Kit (ThermoFisher Scientific, Waltham,
MA, USA) was used to extract genomic DNA. The DNA concentration was measured by
NanoDrop One (ThermoFisher Scientific, Waltham, MA, USA), and the DNA quality was
assessed by standard agarose gel electrophoresis. The genome DNA was further quantified using
a Qubit fluorometer with the double-stranded DNA (dsDNA) high-sensitivity (HS) assay kit
(Invitrogen, Carlsbad, CA, USA), and 5 µg of DNA was used for whole genome sequencing.
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Whole genome sequencing
The whole genome sequencing of E. coli APEC strain APEC-O2-MS1170 was
accomplished with both Illumina short-read sequencing and Nanopore long-read sequencing
strategies.
Illumina DNA sequencing
A total of 2 µg of high molecular weight (HMW) genomic DNA extracted from the strain
APEC-O2-MS1170 was used in Illumina sequencing. The DNA-Seq library preparation and
sequencing were performed in the third-party company (Novogene Inc., Sacramento, CA, USA),
which is subcontracted with the Institute for Genomics, Biocomputing & Biotechnology (IGBB),
Mississippi State University. In brief, the HMW genomic DNA was subjected to the DNA-Seq
library preparation using the TruSeq DNA PCR-free Sample Prep Kit (Illumina, San Diego, CA,
USA). After QC confirmation, the library was sequenced with Pair-End 150 (PE150 or 2 × 150)
sequencing method on an Illumina HiSeq X-Ten sequencer (Illumina, Sand Diego, CA, USA).
Nanopore DNA sequencing
To attain the long-read sequencing, a total of 3 µg of HMW genomic DNA was used for
Nanopore sequencing (Oxford Nanopore Technologies, Oxford, UK), which was conducted in
the Institute for Genomics, Biocomputing & Biotechnology (IGBB), Mississippi State
University. The Nanopore DNA library was prepared by using a Genomic DNA Ligation Kit
(Oxford Nanopore Technologies, Oxford, UK) and followed by sequencing on a Nanopore
GridION sequencer (Oxford Nanopore Technologies, Oxford, UK) for 48-hr run.
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Sequence data assembly and genome annotation
The data generated from both Illumina short-read sequencing and Nanopore long-read
sequencing was analyzed, assembled, and annotated by the IGBB, Mississippi State University.
Sequence alignment and assembly
The Nanopore sequences were assembled into contigs using Canu v1.9 (Schumer et al.,
2017). The overlapping region of each contig was found by aligning the first 1000 bases of each
contig to itself using BLAST v2.9.0 (Camacho et al., 2009). The overlapping regions were
trimmed using Samtools v1.9. The start of each contig that had an overlapping region was moved
upstream of the dnaA gene when present or upstream of the gene closest to the middle of the
contig using Circlator v1.5.5 (Hunt et al., 2015). The Illumina data was mapped to the assembled
contigs using bwa v0.7.17-r1188 (Li, 2013). Any contig without mapped Illumina data was
removed from further analysis. Pilon v1.23 (Walker et al., 2014) used the mappings to correct
any mistakes caused by Nanopore sequencing errors. The Nanopore sequences were mapped to
the corrected contigs using minimap2 v2.17-r941 (De Coster et al., 2018), and the Illumina reads
were remapped using bwa. Bedtools v2.29.2 (Ruepp et al., 2010) was used to calculate coverage
within a 1kb sliding window along with coverage across the entire contig. The best hit from a
BLAST v2.9.0 (Camacho et al., 2009) search against the NCBI Nucleotide collection database
(NT - downloaded 2020/02/16) was used to predict the most likely source of the contig.
Genome annotation
Prokka v1.14.6 (Seemann, 2014) predicted genes on the remaining contigs. Annotations
without an initial start or terminal stop codon, or with an in-frame stop codon were removed
from further analysis. ResFinder v3.2 (Zankari et al., 2012) and CARD v3.0.7 (Tsang et al.,
69

2019) databases were used with BLAST to annotate AMR in the predicted genes. Any predicted
gene with 95% identity and 50% coverage of a database sequence were assigned the
corresponding AMR. Virulent genes were similarly annotated using the genus specific sequences
from the Virulence Factor Database downloaded 2020-02-21 (Liu et al., 2019). Any predicted
gene with 90% identity and 50% coverage of a database sequence were assigned the
corresponding virulence information. InterProScan v5.40-77.0 (Jones et al., 2014) with Panther
database v14.1 (Thomas et al., 2003) was used to annotate the filtered genes functionally. The R
package circulize v0.4.9 (Gu et al., 2014) was used to visualize the assembled genomes.
The in silico multilocus sequence type (MLST) based on eight alleles (dinB, icdA, pabB,
polB, putP, trpA, trpB,and uidA) was obtained using MLST-2.0 and phylotype was performed
with the EzClermont Web Tool, serotyping (O-antigen and flagellin genes) with SerotypeFinder
v2.0, subtyping (fumC and fimH alleles) with CHTyper v1.0 (Gomez-Alvarez and Hoelle, 2019).
Genome assembly verification
The silico predicted junction sites of circular chromosomal DNA assembly and plasmid
DNA assemblies were selected for further confirmation.
Primer design and PCR amplification
To confirm the circular of the genome (chromosomal DNA and plasmid DNA), the junction
sites were verified by PCR. The primers located at the junction site upstream and downstream
500 bp to 1000 bp range were designed for chromosome and plasmids using IDT and NCBI
primer blast tools. The primers were designed with the length of 24-26 nucleotides and 40%60% G/C content, and each primer pair had the melting temperatures within 5 °C difference for
each other. The primers used in this study were listed in Table 3.1. The PCR was conducted with
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a program consisted with an initial heating step of 95 °C for 3 min, the cycling step of 95 °C for
30 s, 55 °C for 30 s, 72 °C for 90 s, running total of 35 cycles, then a final incubation step of 72
°C for 5 min, and final hold at 15 °C to complete the reaction.
After purified by the GeneJET PCR Purification Kit (Thermo ThermoFisher Scientific,
Waltham, MA, USA), the PCR products were analyzed by the 1% agarose gel electrophoresis
with SYBR Safe DNA Gel Stain (Invitrogen, Carlsbad, CA) and visualized under UV light using
the Kodak Gel Logic 200 Imaging System (Eastman Kodak Co., Rochester, NY, USA).
PCR product cloning
The purified PCR products were cloned into the pGEM-T easy vector (Promega, Madison,
WI, USA) followed by the manufacturer’s manual. The ligation reaction was set up as suggested
in the manual. After incubating at 4 °C overnight, 10 µL of ligation product was used to
transform the E. coli competent cells using the heat-shock transformation procedure. The
transformed cells were plated on the LB/Ampicillin (100 µg/mL) agar plates supplemented with
IPTG and X-Gal (for blue-white selection) and followed by the incubation at 37 °C for 18 hours.
Three white colonies were picked from each PCR product cloning, inoculated into the LB broth
with 100 µg/mL Ampicillin, and incubated on an orbital shaker at 37 °C overnight with shaking
speed of 225 rpm.
Plasmid DNA isolation and sequencing
One milliliter of overnight-grown cell culture was transferred into the 1.5-mL centrifuge
tube and centrifuged at 1,000 rpm for 3 min to get the cell pellet. The plasmid DNA was
extracted using the GeneJET Plasmid Miniprep Kit (ThermoFisher Scientific, Waltham, MA,
USA) based on the manufacturer’s protocol. The concentration and quality of plasmid DNA
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were assessed by NanoDrop One (ThermoFisher Scientific, Waltham, MA, USA) and agarose
gel electrophoresis, respectively. The plasmid DNAs from the positive (with correct insert size)
recombinant plasmid colonies were sent to Eurofins Genomics (Louisville, KY, USA) for
Automatic Sanger Sequencing. The sequencing data was used for the confirmation of genome
assembly data.
Results
General genomic features of APEC-O2-MS1170
The detailed coverage number from Illumina and Nanopore showed in Table 3.2. E. coli
strain APEC-O2-MS1170 has a circular chromosome of 4,735,839 bp consisting of 4,066 coding
DNA sequences (CDS), 22 rRNA, 1 tmRNA, and 86 tRNA (Table 3.3). Three plasmids were
identified in the genome with the size of 122,104 bp, 134,406 bp, and 1,552 bp, their CDS are
142, 138, and 2, respectively. MLST analysis showed that strain APEC-O2-MS1170 belonged to
ST127, phylogenetic group B2. The serotype of APEC-O2-MS1170 was O2: H5, and the
CHType was C24: H154.
Plasmid replicons
Plasmid replicon types were analyses through the PLSDB (https://ccb-microbe.cs.unisaarland.de/plsdb/), IncB/O/K/Z, IncFIB, and Col (MG828) replicons were identified in pAPECO2-MS1170-R, pAPEC-O2-MS1170-ColV, and pAPEC-O2-MS1170-3, respectively.
Antimicrobial resistance genes
The resistance gene profile was analyzed and strain APEC-O2-MS1170 carried 7
antimicrobial resistance genes. A MDR efflux pump gene mdf(A) was identified in the APEC72

O2-MS1170 chromosome, and the rest of the resistance genes were detected in the plasmid
pAPEC-O2-MS1170-R as follows: intI1 (class 1 integrase gene), aac(3)-VIa and aadA1
(aminoglycosides), blaCMY-2 (β-lactams), sul1 (sulphonamide), and tetA (tetracycline). In the
previous antimicrobial susceptibility testing (AST) phenotypically, APEC-O2-MS1170 was
detected with resistance to amoxicillin/clavulanic acid, ampicillin, cefoxitin, and ceftriaxone
(blaCMY-2), gentamicin and streptomycin [aac(3)-VIa and aadA1], sulfisoxazole (sul1), and
tetracycline (tetA). Generally, the resistance genotypes correlated well with resistance
phenotypes. No antimicrobial resistance gene was detected from plasmids pAPEC-O2-MS1170ColV and pAPEC-O2-MS1170-3.
Virulence-associated genes
Table 3.4 showed a complete list of virulence-associate gene identified in APEC-O2MS1170 using VFDB database. Seventy-five of the VAGs were identified in the chromosome
APEC-O2-MS1170, which belong to 15 virulence factors from 7 classes which involved in the
adherence, autotransporter, invasion, iron uptake, non-LEE encoded TTSS effectors, regulation,
secretion system and toxin. The chromosome of APEC-O2-MS1170 contains adherence genes
including E. coli common pilus ecpABCDER, outer membrane adhesin eaeH, hemorrhagic E.
coli pilus hcpABC, type I fimbriae fimACDFGHI. Regarding autotransporter and invasion, the
APEC-O2-MS1170 chromosome possessed autotransporter gene ehaB, upaG/ehaG, vat, and
invasion gene ibeABC. For iron uptake, the APEC-O2-MS1170 chromosome have has heme
uptake chuASTUWXY, and yersiniabactin siderophore system (fyuA, irp1, irp2, ybtAEPQSTUX).
The chromosome of APEC-O2-MS1170 contains two type VI secretion systems which encoded
hypothetical proteins belonging to the ACE T6SS and SCI-I T6SS. Besides, the chromosome of
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APEC-O2-MS1170 contains gene usp and hlyE/clyA belong to the Colicin-like Usp and
Hemolysin/cytolysin A are related to produce toxins. From plasmid pAPEC-O2-MS1170-ColV,
nine VAGs were contained, which belong to 2 virulence factors (Iron/manganese transport and
Salmochelin siderophore) from the iron uptake virulence factor class, including sitABCD and
iroBCDEN.
Discussion
Colibacillosis caused by APEC is a significant welfare concern to poultry, and it’s also a
big economic threat to the industry (Fairbrother et al., 2005). Treatment of colibacillosis relies on
antibiotics, however, with the emergence of AMR and MDR among APEC isolates, the
treatment for colibacillosis may be unsuccessful. The multi-drug resistance strain defined in this
study was observed resistant to 8 antimicrobials of 6 antimicrobial agent classes by AST.
However, there are some limitations of understanding the AMR properties of a strain barely
using the AST approach. Due to the practical reason, the strain can only be tested for limited
antimicrobials by either the disc diffusion method or the minimum inhibitory concentration
(MIC). With the advanced WGS technology, it has become a realistic alternative to surveillant
the full list of the antimicrobial genotype information with a single assay (Gordon et al., 2014;
Stoesser et al., 2013).
In this work, we characterized the whole genome sequence of APEC-O2-MS1170 strain
using both the long-read sequencing approach with a Nanopore GridION sequencer (Oxford
Nanopore Technologies, Oxford, UK) and the short-read sequencing approach with an Illumina
HiSeq X-Ten sequencer (Illumina, San Diego, CA, US) to obtain a complete scaffold of the
genome and an accurate sequence. Nanopore is the third-generation sequencing, which is
advantaged in reducing the per-read repeat (McNaughton et al., 2019), besides, it’s user friendly
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due to the low cost and rapid turnaround time, it allows for real-time analysis while sequencing
is going (Petersen et al., 2019). However, there is a concern of using the only Nanopore for
sequencing because of its high raw error rates, including insertions and deletions, and missing
information on the plasmids (Lu et al., 2016). Illumina offers the short-read sequencing platform
with a higher cost, but the advantage of Illumina is the high accuracy of 93% - 95%. Therefore,
in this study, we mainly used the long-read Nanopore sequencing, and combine the short-read
Illumina sequencing to correct the error read and get a high-quality genome sequence of this
strain.
The MDR strain APEC-O2-MS1170 carries abundant antimicrobial resistance genes,
especially in the plasmid pAPEC-O2-MS1170-R. According to Wang et al. (2019) and
Stevenson et al. (2017), horizontal gene transfer (HGT) by plasmids is one of the most
significant pathways to spread antibiotic resistance among bacteria. The ARGs exist in the
plasmid pAPEC-O2-MS1170-R are predicted to resistant to aminoglycosides, β-lactam,
sulphonamide, and tetracyclines, among which, 4 antimicrobials belong to aminoglycosides
(gentamycin and streptomycin), β-lactam (amoxicillin/clavulanic acid), and tetracyclines
(tetracycline) classes were observed phenotypically resistant by APEC-O2-MS1170. In this case,
it confirmed that the AMR genotype from WGS could predict the AMR phenotypes.
The ARGs in the APEC-O2-MS1170 genome are mainly direct the resistance to
macrolide-lincosamide-streptogramin (MLS), aminoglycosides, β-lactam, sulphonamide, and
tetracyclines. Among which, macrolides and lincosamides are common therapeutic agents for
necrotic enteritis in poultry (Dec et al., 2017), antibiotics of aminoglycosides class are widely
used in veterinary medicine to treat the Gram-negative bacilli infection (Almeida et al., 2012),
and tetracyclines are commonly used to treat human and chicken bacterial infections. The
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resistance genes of APEC-O2-MS1170 to these antimicrobials alerting the invalid treatment once
chickens get infected by this strain. Furthermore, if some of the ARGs horizontally transferred to
other pathogens on the farm, it will lose the treatment efficiency by these antimicrobials as well.
Except for the antimicrobial resistance genes, the virulence genes carried by plasmids
were also verified could be horizontally transferred (Coburn et al., 2007). APEC-O1 was
reported highly associated with poultry colisepticemia with a lot of plasmid-encoded virulence
genes (Kariyawasam et al., 2006), such as the iron uptake related genes iro and sit, which also
exist in the pAPEC-O2-MS1170-ColV plasmid of strain APEC-O2-MS1170. As a result, the
presence of plasmid replicons in this APEC isolate suggests that they have the potential to pass
on the ARGs to other non-pathogenic bacteria and making the infection in poultry more difficult
and expensive to treat (Adzitey et al., 2019). With the progress of molecular genetics, more and
more similar pathotype of animal-source strains and human pathogens are revealed, as a result,
some of the animal-derived pathogens are found to be zoonotic (Johnson et al., 2006; MoulinSchouleur et al., 2006). Thus, the strain APEC-O2-MS1170 attracts our attention to detect its
zoonotic possibility. The main functions of the VAGs from the APEC-O2-MS1170 genome are
associated with the pathogenicity, such as adherence, invasion, iron uptake, and toxin (Table
3.4). Human uropathogenic E. coli (UPEC) is a subgroup of the ExPEC infect the human urinary
tract (Sarowska et al., 2019). The carriagASRe of VAGs of APEC-O2-MS1170 demonstrates
some overlapping sequences of ExPEC. The comparison of several characteristics from UPEC
CFT073 and APEC-O2-MS1170 revealed that many VAGs were shared. Interestingly, all of the
overlapping genes of adherence, autotransporter, secretion system, invasion, and toxin function
exist in the chromosome of both APEC-O2-MS1170 and UPEC CFT073. Besides, the presence
of uropathogenic-specific protein gene usp and haemolysin E (hlyE/clyA) identified in APEC76

O2-MS1170 has been significantly associated with ExPEC, thus alerting us to a potential
zoonotic risk that could cause human disease (Sarowska et al., 2019). However, since the
Salmochelin siderophore gene profiles (iroBCDEN) only present in the APEC-O2-MS1170
strain, while the Aerobactin siderophore factors (iucABCD and iutA) only detected in UPEC
CFT073 strain, it’s reasonable to speculate that APEC-O2-MS1170 and UPEC CFT073 have
different adaptability to acquire iron from the host organism (Crosa, 1989; Feldmann et al.,
2007). Additionally, the P fimbriae related genes papACDEFGHIK associated with adherence
property only presented in UPEC CFT073, which is epidemiologically related to infections in
humans and pets (Mulvey et al., 2020), this is a distinguished difference between APEC-O2MS1170 and UPEC CFT073. Therefore, in this study, the WGS data provided well support for
understanding the relationship between strains and aid in the understanding of AMR and
pathogenic mechanisms.
Conclusion
In conclusion, a novel WGS strategy was conducted using both Nanopore long-read and
Illumina short-read and came up with a high throughput genome sequence with high accuracy.
The results of this study demonstrated the whole genome properties of avian pathogenic E. coli
APEC-O2-MS1170, reveal similar virulence properties shared with human ExPEC, therefore
alerting the presence of zoonotic potential. Besides, this study added further depth analyzing the
relationship between genotype and phenotype and contribute to the genetic diversity of APEC
into the gene bank. Furthermore, the genome sequence will aid in the understanding of AMR and
pathogenic mechanisms in this strain using WGS.
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Nucleotide sequence accession numbers
The whole-genome sequence project PRJNA622257 of APEC-O2-MS1170 has been
deposited at DDBJ/EMBL/ GenBank under accession numbers are CP056076-CP056079.
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Table 3.1

Primer designed for the junction site verification

Tig
APEC-O2MS1170
(Chromosome)
pAPEC-O2MS1170-R
(plasmid)
pAPEC-O2MS1170-ColV
(plasmid)
pAPEC-O2MS1170-3
(plasmid)

Primer

Sequence
(5’-3’)

Length

Tm
(°C)

GC%

Forward

GATGTTAAGCTGGTTGTCGTCTGCAC

26

59.9

50

Reverse

CATCGAAGCGACGCTGTTCATAACG

25

60.1

52

Forward

GACGATATTCCGTTTGCCATCTGGTC

26

59.5

50

Reverse

CTATCGCTACGTGACTGGGTCAGG

24

60.5

58

Forward

ATGAAGGCAGGAGTCATGCTGGCTG

25

63.1

56

Reverse

CTCTCCTGCGTCCTAGAGAACTTGC

25

60.5

56

Forward

CTATCAGATGTGAGTCCCTAGCTGGC

26

60.0

54

Reverse

GGTCGAAATCACTCAGAGTCACAACG

26

59.3

50
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Product
length
(bp)
1377
1387
1247
1433

Table 3.2

Summary statistics of sequencing metrics

Sequencing metrics

Illumina platform

Nanopore platform

No. of pairs

3,993,564

180,000

No. of bases (Mb)

1,198

1,375

N50 (bp)

9,337

Coverage (X)

239

80

275

Table 3.3

Summary statistics of whole-genome assemblies

Size (bp)

APEC-O2MS1170
(Chromosome)
4,735,839

pAPEC-O2MS1170-R
(plasmid)
122,104

pAPEC-O2MS1170-ColV
(plasmid)
134,406

pAPEC-O2MS1170-3
(plasmid)
1,552

GC content (%)

51

54

49

52

CDSa

4,066

142

138

2

rRNAs

22

-

-

-

tmRNA

1

-

-

-

tRNAs
CDS, coding DNA sequences

86

-

-

-

Genomic data

Gene annotation data (No.)

a
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Table 3.4

Antimicrobial resistance phenotypic and genotypic characteristics of APEC-O2MS1170

Label

GenBank
accession
no.

ARG(s)a

Predicted resistance
phenotype

Observed resistance phenotypeb

APEC-O2-MS1170
(Chromosome)

CP056077

mdf(A)

Macrolide-LincosamideStreptogramin (MLS)

—

CP056076

aac(3)-VIa,
aadA1,
intI1,
blaCMY-2,
sul1,
tetA

aminoglycosides,
β-lactam,
sulphonamide,
tetracyclines

GEN, STR, AUG2, FOX, AXO,
AMP, FIS, TET,

—

—

—

—

—

—

pAPEC-O2-MS1170R (plasmid)

pAPEC-O2-MS1170CP056079
ColV (plasmid)
pAPEC-O2-MS1170-3
CP056078
(plasmid)
a

ARGs, antimicrobial resistance genes
GEN, gentamicin; STR, streptomycin; AUG2, amoxicillin/clavulanic acid; FOX, cefoxitin;
AXO, ceftriaxone; AMP, ampicillin; FIS, sulfisoxazole; TET, tetracycline
b
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Table 3.5
VFclass

Virulence-associated genes of APEC-O2-MS1170
Virulence factors

APEC-O2-MS1170
APEC-O2-MS1170
pAPEC-O2-MS1170-ColV
(Chromosome)
(plasmid)
orf01191
-

Related
genes
ecpA

E. coli common pilus (ECP)

EaeH
Hemorrhagic E. coli pilus (HCP)
Adherence

orf01192

-

ecpC

orf01193

-

ecpD

orf01194

-

ecpE

orf01195

-

ecpR

orf01190

-

eaeH

orf01182

-

hcpA

orf01413

-

hcpB

orf01414

-

hcpC

orf01415

-

fimA

orf01625

-

fimC

orf01623

-

fimD

orf01622; orf04508

-

fimF

orf01621; orf04509

-

fimG

orf04510

-

fimH

orf01618

-

fimI

orf01624

-

EhaB

ehaB

-

orf01122

UpaG adhesin
Vacuolating autotransporter
gene

upaG/ehaG

orf02359

-

vat

orf01200

-

ibeA

orf01600

-

ibeB

orf00956

-

ibeC

orf02003

chuA

orf02471

-

Type I fimbriae

Invasion

ecpB

Invasion of brain endothelial
cells (Ibes)

Heme uptake

Iron uptake

Iron/manganese transport

Salmochelin siderophore

chuS

orf02472

-

chuT

orf02469

-

chuU

orf02465

-

chuW

orf02468

-

chuX

orf02467

-

chuY

orf02466

-

sitA

-

orf00256

sitB

-

orf00257

sitC

-

orf00258

sitD

-

orf00259

iroB

-

orf00202

iroC

-

orf00201
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Table 3.5 (continued)

Yersiniabactin siderophore

Non-LEE
encoded
TTSS
effectors

EspL1

iroD

-

orf00200

iroE

-

orf00199

iroN

-

orf00198

fyuA

orf04033

-

irp1

orf04037

-

irp2

orf04038

-

ybtA

orf04039

-

ybtE

orf04034

-

ybtP

orf04040

-

ybtQ

orf04041

-

ybtS

orf04043

-

ybtT

orf04035

-

ybtU

orf04036

-

ybtX
espL1

orf04042
orf04331

-

Undetermined

-

aec16

orf01293
orf01287; orf04548;
orf04555
orf01289

aec17

orf01290

-

aec18

orf01291

-

aec19

orf01292

-

aec22

orf01294

-

aec23

orf01295

-

aec24

orf01296

-

aec25

orf01297

-

aec26

orf01298

-

aec27/clpV

orf01299

-

aec28

orf01300

-

aec29

orf01301

-

aec30

orf01302

-

aec31

orf01303

-

aec32

orf01304

-

Undetermined

orf03250

-

Undetermined

orf03249

-

Undetermined

orf03248

-

Undetermined

orf03247

-

aec15

ACE T6SS
Secretion
system

SCI-I T6SS
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Table 3.5 (continued)

Toxin

Undetermined

orf03246

-

Undetermined

orf03245

-

Undetermined

orf03244

-

Undetermined

orf03243

-

Undetermined

orf03236

-

Undetermined

orf03235

-

Undetermined

orf03234

-

Undetermined

orf03233

-

Undetermined

orf03231

-

Undetermined

orf03230

-

Colicin-like Usp

usp

orf01408

-

Hemolysin/cytolysin A

hlyE/clyA

orf04777

-
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CHAPTER IV
PREVALENCE AND ANTIBIOTIC RESISTANCE PROPERTIES OF CAMPYLOBACTER IN
MISSISSIPPI BROILERS
Abstract
Campylobacter causes campylobacteriosis in humans, and it is the main bacterial
pathogen of gastroenteritis in the United States. Poultry and poultry products are common
vehicles of Campylobacter. In-feed antibiotic administration was regarded as an efficient
approach to control foodborne pathogen transmission from poultry to humans. However, the
long-term use of antibiotics can cause antibiotic resistance of Campylobacter. In this study, the
incidence of Campylobacter in the retail chicken and associated farm samples were evaluated.
The antibiotic resistance genes (ARGs) and the growth properties of the isolated Campylobacter
was investigated. A total of 160 retail chicken samples and 254 farm samples were collected in
the state of Mississippi. Microbiological isolation was performed following enrichment
procedures, and then Campylobacter colonies were isolated on Preston selective blood agar. The
identification of Campylobacter and their species were conducted by real-time PCR and 16S
rRNA sequencing. ARG detection was performed by multiplex PCR, and the motility assay was
evaluated for Campylobacter. From a total of 414 poultry retail and farm samples, the overall
prevalence of Campylobacter was found to be 25.4% (105/414), the positive Campylobacter in
retail samples and the farm samples accounted for 36.3% (58/160) and 18.5% (47/254),
respectively. Of the positive isolates, Campylobacter jejuni (C. jejuni) was the predominant
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species, which accounted for 78.1% (82/105), Campylobacter lari (C. lari) and Campylobacter
volucris (C. volucris) accounted for 6.7% (7/105) and 1.9% (2/105), respectively. Up to 17 of the
105 (16.2%) Campylobacter isolates were positive for the tetO gene, followed by 14 (13.3%)
isolates positive for the oxa-61 gene, 11 (10.5%) isolates positive for the aph(3')-IIa gene, and 3
(2.9%) isolates positive for the oxa-184 gene. No aph(2'')-Ig gene was found in any
Campylobacter isolates tested. The motility testing results showed up to 91.8% of tested C.
jejuni have the motility phenotype, among which 12.2% were hyper-motile. In conclusion, this
study provides an update on Campylobacter prevalence in retail poultry products and the poultry
farm. It also provides the novel antibiotic resistance status of the Campylobacter isolates, which
emphasize the necessity of surveillance for antibiotic resistance and call for antibiotic alternative
management strategies for poultry.

Keywords: Campylobacter, antibiotic resistance, real-time PCR detection, virulence gene,
growth performance

Introduction
Campylobacter is the leading cause of bacterial gastroenteritis in humans worldwide
(Debruyne et al., 2008; Englen et al., 2007). Among all species of Campylobacter, C. jejuni
accounted for up to 99% of the human reported infection cases in the United States (Olson et al.,
2008). The economic burden of campylobacteriosis in humans is increasing around the world
(Enokimoto et al., 2007). Besides, C. jejuni infection has a more severe form of Guillain-Barré
syndrome (GBS), which leads to human neurological disorder (Ford et al., 2014).

91

As a foodborne pathogen, Campylobacter commonly exists in swine, cows, cattle,
especially in chicken (Chen et al., 2010; Wieczorek and Osek, 2015). It is transmitted through
poultry meat and poultry products to consumers, which is a great safety concern to humans.
Chicken is the major reservoir of Campylobacter; it provides the Campylobacter growth optimal
temperature at near 42 °C (Horrocks et al., 2009; Park, 2002). Campylobacter colonizes in the
chicken gastrointestinal tracts and easily contaminates the meat during the processing.
Accordingly, raw or undercooked chicken meat is a significant source of human Campylobacter
infection (Fravalo et al., 2020). The frequently contaminated products lead to a significant health
concern. Therefore, Campylobacter control in poultry for maintaining food safety is essential to
reduce human campylobacteriosis.
The application of antibiotic agents has been widely used in both poultry bacterial
infection treatment and human medicine, such as tetracycline, gentamycin, and amoxicillin
(Abdi-Hachesoo et al., 2014; Alfredson and Korolik, 2005). However, the prevalence of
antibiotic-resistant strains has increased the difficulty of Campylobacter control (Alfredson and
Korolik, 2007; Luangtongkum et al., 2009), lots of antibiotic-resistant Campylobacter were
reported by other studies (Alfredson and Korolik, 2007). According to the National Outbreak
Reporting System (NORS), from the year 2008 to 2018, the total Campylobacter outbreak cases
in the United States accounted for 649, which led to 7,127 illness and 438 hospitalizations.
The poultry industry is facing increased demand for “no antibiotic ever (NAE)”
production systems; the products with the NAE label are strictly regulated without any sort of
antibiotic administration at any stage of the chicken life (Smith, 2019). The NAE production
benefits for the prevention of the antibiotic-resistant strains for long-term development.
Consumers and farmers have been increasingly interested in these products with a high
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expectation of food safety and quality. However, the NAE raised chicken is not designed to
prohibit foodborne pathogens because there are strict therapy limitations on the NAE chickens
when they get bacterial infections. There comes the concern that the removal of antibiotics as
disease prevention and therapy may result in the emergence of Campylobacter in broilers. To
date, little is known about the Campylobacter prevalence and antibiotic-resistant properties of
the Campylobacter in Mississippi broilers. Therefore, it’s essential to get the Campylobacter
prevalence and antibiotic resistance information updated.
Campylobacter is motile, and motility is an essential virulence factor associated with the
flagellum (Carrillo et al., 2004). The protein excreta from flagellar organelle promotes the
colonization of Campylobacter to the poultry intestine or mucus layer of the human intestine
(Barrero‐Tobon and Hendrixson, 2014). The flagellum-driven motility enables Campylobacter to
invade into the intestine epithelial cells (Lee et al., 1986). Hence, the motility property of the
flagellum is involved in several steps of the Campylobacter infection process and is highly
associated with virulence. There is a high possibility of Campylobacter virulence when the strain
with higher motile trains.
The present study aimed to investigate the prevalence of Campylobacter in retail chicken
products and associated farm environmental samples and identified the prevalent Campylobacter
species. Besides, we investigated the genotypic antibiotic-resistant properties and phenotypic
motility property of the Campylobacter isolates. The results of this study will contribute to the
Campylobacter prevalence and the antibiotic-resistant surveillance and showing a straight insight
into the Campylobacter phenotypic properties.
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Material and Methods
Sample collection
Raw chicken product samples (whole chicken carcass with giblets) and drumsticks were
purchased from 10 grocery stores in Mississippi between April and July 2019. NAE raised
chicken samples (n = 70), and conventional chicken samples (n = 90) were obtained for the
sampling process. The samples were transported in a cooler and processed within 12 h,
respecting the conditions of hygiene and freshness.
Farm samples, including litter, feces, and cloaca swabs of broilers were collected over 15
different visits to three commercial NAE farms in the state of Mississippi, US, between April
and July 2019. On each sampling day, two houses (each with 4 quadrants) were sampled within
each farm. In each quadrant, 2 samples were randomly picked in separate locations.
Approximately 10 grams of litter on the ground surface (no more than 2.5 cm) and 10 grams of
fresh feces (soft solid or semisolid) were aseptically collected into prelabeled sterile Whirl-Pak
filter bags. Cloaca of randomly selected birds was swabbed with sterile swabs and immersed in a
sterile culture tube with 5 mL of double-strength blood-free Bolton enrichment broth (2 × BFBEB).
Bacterial isolation
The bacterial isolation was performed based on the Microbiology Laboratory Guidebook
(MLG) 41.04 enrichment method provided by the United States Department of Agriculture-Food
Safety and Inspection Service (USDA-FSIS) with some modification (Moran et al., 2011). The
raw poultry product samples (carcass, giblets, and drumsticks) were weighed and added five
times the weight of buffer peptone water (BPW; Thermo Fisher, US), mixed thoroughly by hand
massaging and stomaching. Ten grams of litter and feces samples were prepared for
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Campylobacter enrichment by adding 90 mL of BPW and mixed thoroughly by gently shaking.
Subsequently, transferred 20 mL of the homogenized mixture into 20 mL 2 × BF-BEB and
Bolton broth selective supplements with vancomycin, cefoperazone, trimethoprim, and
amphotericin B to prevent the growth of non-target microorganisms. For the cloaca swab
samples, 5 mL of 2 × BF-BEB with selective supplements was added, make the total amount into
10 mL. The cultures were incubated at 42 °C for 48 h under microaerobic conditions (85%
nitrogen, 10% carbon dioxide, and 5% oxygen) using Mart anaerobic jar with an Anoxomat II
System (Mart Microbiology B. V., Netherlands).
After the enrichment step, each sample and positive control C. jejuni ATCC 33560 and
ATCC 29428 were streaked onto three Campylobacter selective agar for isolation by sterile
plastic 10 μL loops. The Campylobacter selective agar containing Campylobacter agar base
(Thermo Scientific CM0689), selective supplement (Thermo Scientific SR0204E), and 5% laked
horse blood (Thermo Scientific R54072). The agar plates were then incubated under the
microaerophilic condition at 42 °C for 48 h. All agar plates were subsequently checked for the
presence of typical colonies of Campylobacter spp. One completely independent single colony
was selected per plate, and the suspected colony was sub-cultured twice on the selective blood
agar.
Identification of Campylobacter
Campylobacter suspected positive colony from the third-generation sub-cultured agar
were resuspended in the nuclease-free water. The confirmation was conducted via real-time PCR
using a Campylobacter genus-specific primer pair. DNA was prepared using boiled lysates as
previously described with some modification (Mohamed et al., 2018). Briefly, using a sterile
plastic needle to touch a portion of the suspect colony and suspend in 100 μL 1 × PBS, and
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centrifuged to get the bacterial pellet. The supernatant was discarded, and 100 μL nuclease-free
water was added and mixed well by the vortex. The bacteria culture was boiled at 95 °C for 5
minutes. The resulting solution was centrifuged, and the supernatant was transferred into a new
tube and served as the DNA template. The real-time PCR assay was performed using
Campylobacter genus-specific forward primer R-campF2 (5'- CACGTGCTACAATGGCATAT
-3') and reverse primer R-campR2 (5'- GGCTTCATGCTCTCGAGTT -3'). Each reaction
contained 5 μL PowerUp SYBR Green Master Mix (Applied Biosystems, USA), 3.5 μL
nuclease-free water, and 0.25 μL each of the forward and reverse primer (10 μM), and 1 μL of
template DNA. Real-time PCR was performed using QuantStudio 3 (Applied Biosystems, USA)
with the following condition: the initial denature step was 95 °C for 20 s, 40 cycles at 95 °C for 3
s, and 60 °C for 20 s. A melting curve was obtained to analyze the specificity of the primers.
Collected the rest of the pellets from the third-generation sub-culture and kept at -80 °C with
10% skim milk until further analysis (Cody et al., 2008).
Detection of Campylobacter species
The 16S rRNA gene has been used for the rapid detection and identification of species
(Kulkarni et al., 2002). The 16S rRNA gene was amplified from the DNA of the isolates by PCR
using the universal forward primer 27F (5'- AGAGTTTGATCCTGGCTCAG -3') and reverse
primer 1492R (5'- CGGTTACCTTGTTACGACTT -3'). PCR was conducted by using GoTaq
Green Master Mix (Promega, Madison, WI) and an Eppendorf Mastercycler (Eppendorf,
Westbury, NY) under the following conditions: 1 min at 95 °C; and 35 cycles of 30 s
denaturation at 95 °C, 30 s annealing at 60 °C, and 90 s for the extension at 72 °C. According to
the manufacturer's instructions, the PCR products were purified by GeneJET PCR Purification
Kit (Thermo Scientific). The purified PCR products were sequenced by Eurofins Genomics
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(Eurofins, Louisville, KY). The DNA sequences obtained were compared to the information in
the GenBank database using the Basic Local Alignment Search Tool (BLAST) program
available through the National Center for Biotechnology Information website
(www.ncbi.nlm.nih.gov/BLAST).
Detection of antibiotic resistance genes (ARGs)
All the determined Campylobacter isolates were detected for ARGs. The pentaplex PCR
was used to detect ARGs tetO, aph(2”)-lg, aph(3”)-llla, oxa-184, and oxa-61 to 3 antibiotic
agents: tetracycline, gentamicin, and β-lactam. The PCR reaction mix (10 μL) comprised 5 μL
GoTaq Green Master Mix (Promega, Madison, WI), 1.5 μL nuclease-free water, 0.25 μL each of
the forward and reverse primer (10 μM), and 1 μL of template DNA. The PCR was performed
under the following conditions: denaturation at 95 °C for 3 min followed by 35 cycles of 95 °C
for 30 s, 55 °C for 30 s, 72 °C for 1 min, and a final extension step of 72 °C for 5 min. The PCR
primers used in this study are listed in Table 4.1.
Motility assay on semi-solid Muller-Hinton agar
The motility assay was performed as described previously (Pascoe et al., 2019) in semisolid Muller-Hinton plates containing 0.4% agar with modifications. Briefly, Campylobacter
suspensions were adjusted to a turbidity equivalent to a 0.5 McFarland standard, equivalent to
approximately 104 CFU/mL. One mL of standard culture was transferred into 5 mL of MullerHinton broth (Pascoe et al., 2019), and 2 µL culture was pipetted onto the center of the semisolid Muller-Hinton agar. The agar plates were then incubated under the microaerophilic
condition at 42 °C for 48 h. Bacterial motility was assessed by measuring the migration diameter
of bacteria halo. The motility was ranked based on the halo diameter: non-motile isolates did not
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spread across the plate; isolates with halo diameters up to 1.5 cm were categorized as motile; and
those with halos of diameter above 1.5 cm were designated as hyper-motile (Senior et al., 2011).
Reference strains
Two Campylobacter reference strains were included in the study: C. jejuni ATCC 33560
(CCM 6214) and C. jejuni ATCC 29428.
Experiment design and data analysis
A completely randomized design was used to evaluate the incidence of Campylobacter.
Statistical analysis was performed by the Chi-square test using the SAS9.4 software (Institute
Inc., Cary, NC, USA). Differences among means with the P-value less than 0.05 were accepted
as statistically significant.
Results
Prevalence of Campylobacter in retail and farm samples
The overall prevalence of Campylobacter among 414 of poultry samples was 25.4% (105
out of 414). Table 4.2 shows that in the retail samples, there were 36.3% (58 out of 160) of
samples contaminated with Campylobacter, the percentage of NAE chickens was 31.4% (22 out
of 70), and conventional was 40.0% (36 out of 90). Among NAE and conventional chickens, no
significant difference in prevalence was observed (P = 0.1138). From farm samples, a total of
18.5% (47 out of 254) were detected with Campylobacter positive, from which the litter, feces,
and cloaca swab samples were account for 13.6% (14 out of 103), 21.6% (16 out of 74), 22.1%
(17 out of 77) respectively. The prevalence of Campylobacter in feces was significantly higher
than litter (P = 0.0293). There was also a trend showing the Campylobacter prevalence in cloaca
swab samples higher than the litter, where the P-value was barely greater than 0.05 (P = 0.0526).
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Among the retail chickens and the farm samples involved in this research, the statistical
comparison showed that retail chickens were found with a significantly higher prevalence of
Campylobacter than farm samples (P < 0.0001). Table 4.3 shows the detailed source of
Campylobacter isolated from the retail chickens. No Campylobacter was found in the drumsticks
of both NAE and conventional samples. For chicken carcasses, 44.0% of positive was found in
the NAE samples. The conventional chicken carcasses were detected with the highest prevalence
among the retail samples, which of 57.1%. A similar percentage of Campylobacter was detected
in giblets from NAE and conventional samples, 44.0% and 45.7%, respectively.
Identification of Campylobacter species
A total of 22 Campylobacter were isolated from NAE chickens, 36 from the
conventional, and 47 from the farm. The distribution of species within the Campylobacter
isolates was analyzed, and the results are shown in Table 4.4. C. jejuni was the predominant
species in all types of samples, and significantly higher than other species, which accounted for
78.1% (82/105) in total. Campylobacter lari (C. lari) and Campylobacter volucris (C. volucris)
were following with the prevalence of 6.7% (7/105) and 1.9% (2/105). Other species accounted
for 13.3% (14/105) in total. Retail conventional samples contain all of the three detected
Campylobacter species, no C. lari and C. volucris were found in retail samples, and no C.
volucris found in farm samples.
Detection of ARGs
All of the Campylobacter isolates were tested for ARGs showing in Table 4.5. Except for
the gentamicin resistance gene aph(2'')-Ig, all of the other four ARGs were detected in C. jejuni.
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The gene aph(3')-IIa, which is of a similar function as aph(2'')-Ig presented in 11 (10.5%)
isolates. The tetracycline resistance gene tetO was the most prevalent, which existed in 17
(16.2%) isolates. Besides, the β-lactamase resistance gene oxa-184 was only found in C. jejuni,
which was carried by 3 (2.9%) isolates. Another β-lactamase resistance gene oxa-61 was the only
one found in all three detected Campylobacter species, which was carried by 14 (13.3%) isolates;
oxa-61 was the only ARG carried by C. lari and C. volucris among detected ARGs.
C. jejuni Motility
Motility is one of the essential virulence properties of C. jejuni, and it is related to the
colonization and invasion properties by flagella (Morooka et al., 1985). Table 4.6 shows the
motility of 49 C. jejuni isolates from all the C. jejuni of this study. Most of the C. jejuni isolates
were motile or hyper-motile, which accounted for 79.6% (39/49) and 12.2% (6/49). Only 8.2%
(4/49) of the detected strains were non-motile.
Discussion
The present study results indicate that Campylobacter was highly prevalent in poultry
from retail stores and the commercial farm in Mississippi. There were 36.3% of retail chicken
samples tested for Campylobacter positive. This finding is generally consistent with previous
studies, which found the prevalence of Campylobacter in chicken carcasses ranging between 0
and 58% (Bailey et al., 2019; Han et al., 2009). Accordantly, similar research on the
investigation of Campylobacter in retail raw chickens in the Greater Washington, D.C. reported
that the incidence was 25.2% (Zhao et al., 2001). All these relevant researches above were
conducted in the U.S. Whereas, another study in the U.K. reported that Campylobacter
contamination was up to 75% of chicken carcasses (Sibanda et al., 2018). A similar
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Campylobacter prevalence of 73.3% was reported by a survey conducted in the U.K. in 2015
(https://www.gov.uk/government/publications). The reason for the different prevalence of
Campylobacter in retail chickens can be explained by the different sampling regions and the
producers.
Although Campylobacter was frequently recovered from retail chicken carcasses, no
Campylobacter contamination was found from the tested drumsticks. The possible reason is that
the raw carcasses are easily contaminated with Campylobacter from the gut or leaking intestine
during processing. While during the evisceration process, drumsticks are not contacted with the
internal organ and intestines. However, there was a comparative study investigating
Campylobacter incidence, specifically in the chicken drumsticks and wings. The result reveals
that the contamination on the examined drumsticks was 45.5% (Kudirkiene et al., 2013), which
may happen during the plucking process or chilling process. The variation in the results from
different studies, depending on the sample condition (fresh or frozen), sample preparation (rising
or homogenizing), bacterial isolation methods (direct counting or enrichment) (Baylis et al.,
2000; Musgrove et al., 2001; Wingstrand et al., 2006).
There was no significant difference in the Campylobacter incidence among the NAE
chickens and conventional chickens from the present study. It indicates that NAE chickens did
not perform better than conventional chickens on reducing the Campylobacter incidence.
Chickens raised with no antibiotics ever require high quality of housing environment and better
disease control. However, the removal of antibiotics on the farm possibly related to the increase
of food-borne Campylobacter contamination.
As for commercial farm samples, the overall incidence of Campylobacter was up to
18.5%. The fecal and cloacal samples from the poultry farm are the representative indicators to
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the farm environment as described by Montrose et al. (1985) and Ingresa-Capaccioni et al.
(2015). Previous studies showed the Campylobacter prevalence was 73% to 85.7 % in the fecal
samples from conventional free-range broilers (Bailey et al., 2019; Rivoal et al., 1999), which
were much higher than our result. However, the farm that we sampled was an NAE farm. The
lower Campylobacter incidence of fecal samples than the conventional farm samples was similar
to the study from Bailey et al. (2019), they found the percentage of Campylobacter positive
samples in the NAE farms was significantly lower than the conventional farms (Bailey et al.,
2019). The possible reason for this result is that the NAE farm is required to high standard
hygiene and better disease control (Smith, 2019); therefore, the prevalence of Campylobacter is
lower in NAE farms. The Campylobacter incidence of the cloaca swabs was almost the same as
feces samples; however, the Campylobacter in the litter was significantly lower than in the feces.
The possible reason is that the fresh feces maintain the temperature and anaerobic environments
that benefit the Campylobacter survive. In contrast, the temperature, moisture, and anaerobic
conditions in the litter are different, leading to the low survival rate of Campylobacter.
Another important finding showed that the Campylobacter prevalence in the retail
samples was higher than the farm samples. It indicates the possibility of Campylobacter
contamination during processing. This finding is supported by Berrang et al. (2001), who
indicated that the increase in the recovery of Campylobacter in processing is related to the feces
contamination during defeathering. This finding is also consistent with the study conducted by
Rivoal et al. (1999), who reported that the high amount of Campylobacter distribution in the
poultry product may due to cross-contamination of the leaking intestinal tract during the
processing.

102

Among Campylobacter species, C. jejuni is most associated with human
campylobacteriosis, affect humans mainly by raw and undercooked chicken (Riddle et al., 2012).
In this study, C. jejuni was the predominant species isolated from all Campylobacter isolates,
accounted for 78.1% in total. Numerous studies have reported similar isolation rates of C. jejuni
from poultry (Hofshagen and Kruse, 2005; Luangtongkum et al., 2006; Wieczorek and Osek,
2015), where the C. jejuni was the highly prevalent species with the prevalence from 68.7% to
91%. However, this result contrasts to the earlier study performed in turkey, Kashoma et al.
reported that C coli was the most prevalent species that accounted for 72.3% in all
Campylobacter isolates (Kashoma et al., 2014). No C. coli was detected from the broiler farm
and products in our study, which can be well illustrated by a research in 2010, indicating that the
proportion of the isolates species varied among animal species (Hazards, 2010). Even in other
studies that found the C. coli in broiler flocks, it is always of a lower proportion than C. jejuni
(Hofshagen and Kruse, 2005; Wieczorek and Osek, 2015).
The ARGs detected in this study are highly related to the antibiotic agents used as poultry
bacterial infection treatment or clinical treatments. The genes direct the resistance to βlactamases tested in this study, including oxa-184 and oxa-61.β-lactamases antibiotics, which
were considered the first list drugs to treat staphylococcal infections in poultry (Agyare et al.,
2018). Although β-lactamases antibiotics are not mainly used as Campylobacter infection
therapy, Lachance et al. (1991) reported that 83% to 92% Campylobacter strains were confirmed
produce β-lactamases that resistant to amoxicillin, ampicillin, and ticarcillin. Gene tetO is a
typical tetracycline resistance gene (Abdi-Hachesoo et al., 2014), which was detected from
17.5% of the Campylobacter isolates in this study. Tetracycline is a common therapy in poultry
bacterial infection (Rahimi et al., 2010). It possibly increases the incidence of tetracycline
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resistance of the Campylobacter isolated from poultry. Tetracycline has also been listed as an
alternative therapy for human Campylobacter gastroenteritis (Reddy and Zishiri, 2017).
However, the high ratio of tetracycline resistance may cause unsuccessful treatment for the
Campylobacter infection for humans.
Motility is a very important property in bacteria. It’s related to the flagellar motor and
reacts by changing direction and rotation (Armitage, 1999), helping the bacteria dispersal in the
environment or the transmission route. On the other hand, motility is also an important character
of such pathogens to access the colonization sites and infect the host in either animal or human
(Josenhans and Suerbaum, 2002). The higher motility of the Campylobacter, the higher risk of
the infection within the thick mucus layer lining the intestinal (Hazell et al., 1986; Lertsethtakarn
et al., 2011). In this study, up to 91.8% of the tested Campylobacter isolates are motile, which
alerts the strong virulent capability of theses strains to transmit through the environment and
colonize the intestinal mucus.
Conclusion
To sum up, this study provides updated data on Campylobacter surveillance in
Mississippi poultry. And it verified the retail NAE chicken could not avoid the Campylobacter
contamination compare to the conventional chicken. Thus, the presence of Campylobacter in
both NAE and conventional products, as well as the detection of antibiotic resistance isolates,
alerting that the chicken consumption potentially causes human campylobacteriosis and the
antibiotic alternative control measures are of great necessity.
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Table 4.1
Primer
tetO
aph(2”)-lg
aph(3”)-llla
oxa-184
oxa-61

Primers used for the ARGs amplification
Sequence (5’-3’)
Forward
AATATTCAGAGAAAAGGCGGCG
GATTTACCTGCCTTGATTCCGG
TGCACTTTGAACGGCATGATG
GCTCTCAAGTGCCTGCTTTT
CTTTCTCTCCCGCTTCCACT

105

Reverse
GCAGCCATAAAGAACCCCCT
TTCGCCCGAAATCTTTCCCA
TGTCATACCACTTGTCCGCC
AAATCCAACAATCCAAGCCAAA
ACCAATTCTTCTTGCCACTTCTTT

Size (bp)
686
523
432
317
203

Table 4.2

Prevalence of Campylobacter in poultry

Sample Positive
Prevalence
SEM1 (%)
number isolates
(%)
NAE chicken
70
22
31.4
5.59
Retail
Conventional chicken 90
36
40.0
5.20
samples
P-value
0.1138
Litter
103
14
13.6b
3.39
Feces
74
16
21.6a
4.82
Farm
ab
samples Cloacal swab
77
17
22.1
4.76
P-value
0.0496
Retail samples
160
58
36.3a
3.81
b
Total
Farm samples
254
47
18.5
2.44
P-value
<.0001
a,b
Means in a column not sharing a common superscript were different (P < 0.05)
1
SEM, Standard error of mean
Sample source
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Table 4.3

Prevalence of Campylobacter in retail samples

Sample
source
Drumstick
Carcass
NAE
Giblet
P-value
Drumstick
Carcass
Conventional
Giblet
P-value
1
SEM, Standard error of mean

Sample
number
20
25
25

Positive
isolates
0
11
11

20
35
35

0
20
16
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Prevalence
(%)
0
44.0
44.0
0.6997
0
57.1
45.7
0.0821

SEM1 (%)
0
10.13
10.13
0
8.49
8.54

Table 4.4

Species of Campylobacter isolates

Retail
Farm
NAE
SEM
SEM1 samples
samples
(n = 47)
(n = 22)
C. jejuni
22 a
0.0812
20 a
0.0613
40 a
b
b
C. lari
4
0.0524
0
0
3b
b
b
C. volucris
2
0.0693
0
0
0b
b
b
Other
8
0.0382
2
0.0002
4b
P-value
<.0001
0.0002
<.0001
a,b Means in a column not sharing a common superscript were different (P < 0.05)
1
SEM, Standard error of mean
Campylobacter
spp.

Retail conventional
samples (n = 36)

1
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1

SEM

0.0519
0.0407
0
0.0407

Total
incidence
(%)
(n = 105)
82 (78.1%)
7 (6.7%)
2 (1.9%)
14 (13.3%)

Table 4.5

ARGs of Campylobacter isolates

ARGs

Predicted resistance

C. jejuni
(n = 82)

C. lari
(n = 7)

C. volucris
(n = 2)

Other
(n = 14)

aph(2'')-Ig
aph(3')-IIa
oxa-184
oxa-61
tetO

aminoglycoside
aminoglycoside
β-lactamases
β-lactamases
tetracycline

0
9
3
7
12

0
0
0
1
0

0
0
0
1
0

0
2
0
5
5
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Table 4.6

C. jejuni motility

Motility
Non-motile
Motile
Hyper-motile

Number (n = 49)
4
39
6
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Percentage (%)
8.2
79.6
12.2
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CHAPTER V
SUMMARY
Current Findings
APEC and Campylobacter are the common pathogens exist in the poultry flocks and
poultry products. The long-term use of antimicrobials as growth promoters and pathogen
infection therapy has increased the antimicrobial resistance of APEC and Campylobacter in
poultry globally. The efforts on monitoring the prevalence and antimicrobial resistance status
have been shown in more and more studies. Besides, research on antimicrobial alternatives has
become a hot topic in order to relieve the pressure caused by multi-drug resistant bacteria. The
chapters in this study focus on the investigation of APEC and Campylobacter prevalence in
Mississippi poultry, and the antimicrobial properties of the isolated strain. Probiotics have been
verified with a positive effect reducing pathogen colonization in poultry; there is still an
uncertain effect of particular probiotic strains on reducing the APEC prevalence in broilers.
The first objective of this study was to evaluate the effect of in ovo administration of
Lactobacillus probiotics on the incidence of APEC in broilers and determine the virulence and
antimicrobial resistance properties of APEC isolates. The results showed a high prevalence of
APEC isolated from the broiler organs; however, no difference was observed of the APEC
prevalence among probiotic treatments. It was found that the APEC isolates frequently carry
antimicrobial resistance genes that direct the resistance to different classes antimicrobial agents;
some of the isolates were even multi-drug resistant. A new finding from this study is that the
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probiotics treatment may affect the distribution of some antimicrobial resistance genes, which
can be further confirmed.
The second objective of this study was to characterize the genome sequence of the multidrug resistant strain APEC-O2-MS1170 by whole genome sequencing; identify the antimicrobial
resistance genotype-phenotype relationships and the virulence profiles. In this study, the
complete genome of strain APEC-O2-MS1170 revealed a strong relationship between the
antimicrobial resistance genotype and phenotype. It indicated the potential resistance genes and
virulence genes transmission by the plasmid. Some virulence genes carried by this strain were
found similar to human ExPEC, which alerts the presence of zoonotic potential.
The third objective of this study was to investigate the prevalence of Campylobacter in
retail chicken products and associated farm environmental samples, identified the prevalent
Campylobacter species and their associated antibiotic resistance properties. From the current
study, the results showed the Campylobacter contamination in the retail chickens were higher
than the farm environmental samples, and the NAE chicken products did not perform better on
avoiding Campylobacter contamination than the conventional chickens in retail. The
Campylobacter isolates were found carrying the genes that resistant to the antibiotics commonly
used as clinical treatments. Besides, most of the Campylobacter isolates were found to be motile
or hyper-motile, which related the strong ability of colonization.
Recommendation
The overall finding of this study indicates that the prevalence of APEC and
Campylobacter in poultry is at a high level, and their antimicrobial resistance is still a serious
problem, which requires the antimicrobial alternative controls. The effect of probiotics on
reducing pathogens in broilers was previously revealed. Although the Lactobacillus strains used
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in this study did not protect against the APEC prevalence in broilers, it can not represent all
probiotic strains. Also, the probiotic strains have been tested in animal research were limited; not
all probiotic can be tested in reality. Besides, the effect of the probiotics on the presence of
antimicrobial resistance genes is uncertain yet. Therefore, it can be concluded that more effort on
the probiotic exploration as antimicrobial alternatives is needed.
Implication and Future Research
In this study, the investigation on the APEC and Campylobacter prevalence provides the
updated data for APEC and Campylobacter surveillance in Mississippi poultry currently. The
antimicrobial resistance and virulence properties of these isolates challenged the pathogen
control efficiency either in poultry farms or poultry products. The exploration of the APEC
whole genome in this study provides a clue on the antimicrobial resistance mechanism, warning
the use of some antimicrobials, which also provided information on the new drug development.
Besides, the in ovo inoculation of the three single Lactobacillus did not perform as good as the
in-feed probiotic administration; therefore, in further research, either the in-feed probiotic
administration or the probiotic mix can be investigated on reducing the APEC colonization in
vivo. As for Campylobacter, four representative C. jejuni isolates have been selected for whole
genome sequencing in order to investigate the further antimicrobial resistance mechanism and
the virulence properties of C. jejuni.
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